GLP-1 Market
LLY $1181.89 ▲ +2.7% NVO $38.62 ▲ +1.2% PFE $28.41 ▲ +0.8% VKTX $36.75 ▼ -11.8% KLRA $11.98 ▼ -8.8% GPCR $36.02 ▲ +0.2% RHHBY $54.80 ▼ -0.5%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Angiotensin Ii

Company
Amy Arnold
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
47 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

47 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 25, 2026

Find a Clinical Trial Near Me

See recruiting studies for Angiotensin Ii and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02560805

    Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV

    Not yet reported Emory University 134 participants Est. completion 2027-03-30 1 site
    Other conditions: Stress Disorders, Post-Traumatic
    View official trial listing →
  • Recruiting NCT NCT02735707

    Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

    Not yet reported UMC Utrecht 20000 participants Est. completion 2028-02 408 sites
    Other conditions: Community-acquired Pneumonia, Influenza, COVID-19
    View official trial listing →
  • Recruiting NCT NCT02770066

    A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension

    University of Aarhus 160 participants Est. completion 2035-01 5 sites
    Cardiovascular disease Other conditions: Renal Artery Obstruction, Hypertension, Renovascular, Kidney Diseases
    View official trial listing →
  • Recruiting NCT NCT02818517

    Evaluation and Management of Cardio Toxicity in Oncologic Patients

    Tel-Aviv Sourasky Medical Center 1000 participants Est. completion 2031-12-31 1 site
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT03806283

    Mechanisms of Pregnancy Vascular Adaptations

    University of Wisconsin, Madison 166 participants Est. completion 2027-04 1 site
    Other conditions: Pre-Eclampsia, Vascular Diseases
    View official trial listing →
  • Recruiting NCT NCT04367883

    Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection

    Consorci Sanitari de Terrassa 3000 participants Est. completion 2028-02-24 1 site
    Other conditions: COVID19, Influenza Vaccination, ACE Inhibitors, ARB, Antihistamine Allergy, Amantadine
    View official trial listing →
  • Recruiting NCT NCT04456816

    A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria

    Not yet reported SynAct Pharma Aps 23 participants Est. completion 2026-06-30 1 site
    Other conditions: Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy, Severe Proteinuria Due to Idiopathic Membranous Nephropathy
    View official trial listing →
  • Recruiting NCT NCT04520048

    Vascular Biomarkers Predictive of the Progression From Hypertensive Disorders in Pregnancy to Preeclampsia in Pregnant Women

    Not yet reported Assistance Publique - Hôpitaux de Paris 110 participants Est. completion 2026-12 3 sites Stand-alone
    Other conditions: Hypertension Disorders in Pregnancy, Gestational Hypertension, Pre-Eclampsia
    View official trial listing →
  • Recruiting NCT NCT04662723

    Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

    Not yet reported Fondazione Schena 878 participants Est. completion 2028-12-31 2 sites Stand-alone
    Other conditions: Glomerulonephritis, Immunoglobulin A Nephropathy
    View official trial listing →
  • Recruiting NCT NCT04763577

    Bradykinin-degradating Enzymes Activities in Angiotensin-Converting Enzyme Inhibitors-associated Angioedema

    University Hospital, Grenoble 243 participants Est. completion 2025-10-26 4 sites
    Other conditions: Angio-Oedema Caused by Angiotensin-Converting-Enzyme Inhibitor
    View official trial listing →
  • Recruiting NCT NCT04768322

    LVAD Versus GDMT in Ambulatory Advanced Heart Failure Patients

    Not yet reported Hospices Civils de Lyon 92 participants Est. completion 2029-02 8 sites Stand-alone
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT04962711

    Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM)

    Not yet reported Baker Heart and Diabetes Institute 685 participants Est. completion 2025-12-31 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT04971720

    PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis

    Not yet reported, Not yet reported University of Alabama at Birmingham 160 participants Est. completion 2027-01-01 1 site Stand-alone
    Cardiovascular disease Other conditions: Obesity, Hypertension, Nocturnal Blood Pressure, Natriuretic Peptides, Renin-Angiotensin-Aldosterone System
    View official trial listing →
  • Recruiting NCT NCT04983823

    Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)

    Not yet reported Baker Heart and Diabetes Institute 820 participants Est. completion 2025-12-30 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT05183646

    A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

    Not yet reported Dimerix Bioscience Pty Ltd 286 participants Est. completion 2029-12 220 sites
    Other conditions: FSGS
    View official trial listing →
  • Recruiting NCT NCT05442463

    Hormone Therapy and Angiotensin-Dependent Arterial and Renal Vasoconstriction in Humans

    University of Calgary 200 participants Est. completion 2025-11-30 1 site
    Other conditions: Hormone Therapy
    View official trial listing →
  • Recruiting NCT NCT05498675

    Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study

    Beijing Friendship Hospital 180 participants Est. completion 2027-06-30 1 site
    Other conditions: Sacubitril/Valsartan, Hypertension, Obesity
    View official trial listing →
  • Recruiting NCT NCT05839314

    Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy

    Not yet reported Chinese PLA General Hospital 480 participants Est. completion 2027-07-01 1 site Stand-alone
    Other conditions: Nephropathy, Glomerular Diseases, Idiopathic Membranous Nephropathy
    View official trial listing →
  • Recruiting NCT NCT05855746

    Colchicine Versus Placebo in Acute Myocarditis Patients

    Not yet reported Assistance Publique - Hôpitaux de Paris 300 participants Est. completion 2028-07-16 2 sites Stand-alone
    Other conditions: Acute Myocarditis
    View official trial listing →
  • Recruiting NCT NCT05937841

    Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia

    Not yet reported Anna Stanhewicz, PhD 30 participants Est. completion 2026-06-01 1 site
    Other conditions: Preeclampsia Postpartum
    View official trial listing →
  • Recruiting NCT NCT05942027

    Role of Coenzyme Q10 in Chronic Kidney Disease

    Not yet reported Tanta University 44 participants Est. completion 2026-07-15 1 site
    Chronic kidney disease
    View official trial listing →
  • Recruiting NCT NCT05942053

    Role of Vitamin K2 in Chronic Kidney Disease

    Not yet reported Tanta University 44 participants Est. completion 2026-07-15 1 site
    Chronic kidney disease
    View official trial listing →
  • Recruiting NCT NCT06023576

    A Study of Blood Pressure Control During Cancer Treatment

    Not yet reported Memorial Sloan Kettering Cancer Center 130 participants Est. completion 2029-05-30 7 sites Stand-alone
    Other conditions: Breast Cancer, Cardiotoxicity
    View official trial listing →
  • Recruiting NCT NCT06150560

    A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)

    Not yet reported Mayo Clinic 120 participants Est. completion 2028-06-01 1 site
    Other conditions: Coarctation of Aorta, High Blood Pressure
    View official trial listing →
  • Recruiting NCT NCT06183437

    The STOP-MED CTRCD Trial

    Not yet reported Dinesh Thavendiranathan 335 participants Est. completion 2031-12 14 sites Stand-alone
    Heart failure Other conditions: Cardiotoxicity, Cardiac Toxicity, Antineoplastics Toxicity, Cancer
    View official trial listing →
  • Recruiting NCT NCT06218199

    Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts

    Not yet reported Heart Center Research, LLC 80 participants Est. completion 2026-12-31 1 site
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT06282965

    Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury

    Not yet reported, Not yet reported University of Arizona 90 participants Est. completion 2027-09 1 site Stand-alone
    Other conditions: Traumatic Brain Injury
    View official trial listing →
  • Recruiting NCT NCT06482853

    Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension

    Not yet reported Milton S. Hershey Medical Center 52 participants Est. completion 2029-03 1 site Stand-alone
    Other conditions: Obesity, Hypertension
    View official trial listing →
  • Recruiting NCT NCT06562582

    STunning in Acute Myocardial Infarction - BAS

    Not yet reported Vastra Gotaland Region 120 participants Est. completion 2027-12-31 1 site
    Other conditions: Myocardial Infarct
    View official trial listing →
  • Recruiting NCT NCT06625346

    Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients.

    The Searle Company Limited Pakistan 420 participants Est. completion 2025-09-15 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Recruiting NCT NCT06655480

    Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF

    Not yet reported National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 50 participants Est. completion 2027-12-31 1 site
    Heart failure Other conditions: LVDD, Myocardial Fibrosis
    View official trial listing →
  • Recruiting NCT NCT06711432

    Different Intraoperative Blood Pressure Management on Postoperative Cognitive Function in Tumor Patients(PRECISION)

    Not yet reported Zhejiang Cancer Hospital 214 participants Est. completion 2026-06-01 1 site Stand-alone
    Cardiovascular disease Other conditions: Tumor
    View official trial listing →
  • Recruiting NCT NCT06853951

    Cardioprotection on Chemotherapy-Induced Cardiotoxicity

    Not yet reported Ain Shams University 30 participants Est. completion 2025-07-18 2 sites
    Other conditions: Cardiotoxicity
    View official trial listing →
  • Recruiting NCT NCT06917664

    Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease

    Not yet reported China National Center for Cardiovascular Diseases 220 participants Est. completion 2027-06 1 site
    Cardiovascular disease Other conditions: Ischemic Mitral Regurgitation, Angiotensin Receptor/Neprilysin Inhibitor
    View official trial listing →
  • Recruiting NCT NCT06918756

    Development of a Cough Control Questionnaire (CCQ)

    King's College Hospital NHS Trust 100 participants Est. completion 2031-09-01 1 site
    Other conditions: Cough
    View official trial listing →
  • Recruiting NCT NCT06975111

    Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

    Not yet reported, Not yet reported University of Colorado, Denver 200 participants Est. completion 2030-10-01 3 sites
    Other conditions: Menopause, Menopause Hot Flashes, Menopause Related Conditions, Cardiovascular
    View official trial listing →
  • Recruiting NCT NCT07099859

    Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery.

    Not yet reported Vitor Emer Egypto Rosa 60 participants Est. completion 2029-07-01 1 site
    Heart failure Other conditions: Heart Valve Diseases, Left Ventricle Remodeling, Aortic Regurgitation Disease, Natriuretic Peptide, Brain
    View official trial listing →
  • Recruiting NCT NCT07167368

    Exercise Rehabilitation for Cardiorenal Syndrome in HFrEF Patients

    Not yet reported Haiyan Pan 60 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Cardiorenal Syndrome
    View official trial listing →
  • Recruiting NCT NCT07181109

    Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

    Not yet reported Alnylam Pharmaceuticals 11000 participants Est. completion 2030-09-23 1153 sites
    Cardiovascular disease Other conditions: Hypertension, High Cardiovascular Risk
    View official trial listing →
  • Recruiting NCT NCT07312292

    Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose (RADIANT)

    Not yet reported Niek Wijnen 15 participants Est. completion 2027-11-01 1 site Stand-alone
    Other conditions: Liver Cancer (Locally Advanced or Metastatic), Liver Cancer Adult
    View official trial listing →
  • Recruiting NCT NCT07347925

    Effect of Pre-Hospital ARNI Therapy on Short-Term Outcomes in HFrEF

    Future University in Egypt 140 participants Est. completion 2026-05-01 1 site
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT07355023

    AI-Enabled Electrocardiogram-Guided Guideline-Directed Medical Therapy on Incident Left Ventricular Dysfunction: A Target Trial Emulation Study

    Not yet reported Tri-Service General Hospital (TSGH) 5000 participants Est. completion 2026-01-15 1 site Stand-alone
    Other conditions: Left Ventricular (LV) Systolic Dysfunction
    View official trial listing →
  • Recruiting NCT NCT07513883

    The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission.

    Not yet reported Ziekenhuis Oost-Limburg 100 participants Est. completion 2028-12 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT07572032

    Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study

    Not yet reported Kyungsub Song 80 participants Est. completion 2028-12-20 4 sites
    Cardiovascular diseaseHeart failure Other conditions: Valvular Cardiomyopathy
    View official trial listing →
  • Recruiting NCT NCT07631156

    STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure

    Not yet reported Kyungsub Song 80 participants Est. completion 2029-12-30 5 sites Stand-alone
    Heart failure Other conditions: Ventricular Dysfunction, Left
    View official trial listing →
  • Recruiting NCT NCT07683585

    Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary Intervention

    Not yet reported National Medical Research Center for Therapy and Preventive Medicine 207 participants Est. completion 2026-09 1 site
    Other conditions: Hypertension, Coronary Arterial Disease, Percutaneous Coronary Intervention
    View official trial listing →
  • Recruiting NCT NCT07685938

    Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

    Not yet reported UNC Lineberger Comprehensive Cancer Center 60 participants Est. completion 2029-02 1 site Stand-alone
    Other conditions: Chest Wall Tumor, Breast Cancer, Lung Cancer, Esophageal Cancer, Mediastinal Cancers, Spine Metastases, Spinal Tumor, Thoracic Cancer, Thoracic Neoplasms
    View official trial listing →
  • Completed NCT NCT00001741

    Study of Inherited Changes of Receptors Located on Blood Vessels

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 200 participants Est. completion 2003-04 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00005928

    Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 25 participants Est. completion 2002-02 1 site
    Other conditions: Atherosclerosis, Coronary Disease, Vasculitis
    View official trial listing →
  • Completed NCT NCT00006305

    Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes

    Not yet reported University of Pittsburgh 2368 participants Est. completion 2009-03
    Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Insulin Resistance, Diabetes Mellitus, Diabetes Mellitus, Non-Insulin-Dependent
    View official trial listing →
  • Completed NCT NCT00006328

    Angiotensin-Converting Enzyme Gene Polymorphism and the Risk of Chronic Allograft Nephropathy

    National Center for Research Resources (NCRR) 1 site
    Other conditions: Kidney Disease
    View official trial listing →
  • Completed NCT NCT00063492

    Angiotensinogen Gene and Human Hypertension

    University of Utah Est. completion 2007-12
    Cardiovascular disease Other conditions: Heart Diseases, Hypertension
    View official trial listing →
  • Completed NCT NCT00098137

    Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation

    Not yet reported Atrial Fibrillation Network 422 participants Est. completion 2009-05
    Other conditions: Heart Disease, Arrhythmia, Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00108082

    The CLEVER Study - Coreg And Left Ventricular Mass Regression

    Not yet reported GlaxoSmithKline 287 participants Est. completion 2008-08 78 sites
    Other conditions: Hypertrophy, Left Ventricular
    View official trial listing →
  • Status unknown NCT NCT00108706

    Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)

    Not yet reported City Hospitals Sunderland NHS Foundation Trust 50 participants Est. completion 2007-09 1 site
    Cardiovascular disease Other conditions: Cerebrovascular Accident
    View official trial listing →
  • Completed NCT NCT00113087

    Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart Network

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 230 participants Est. completion 2008-07 9 sites
    Heart failure Other conditions: Heart Defects, Congenital
    View official trial listing →
  • Completed NCT NCT00118976

    Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease

    Not yet reported Steno Diabetes Center Copenhagen 60 participants Est. completion 2006-09 1 site
    Chronic kidney disease Other conditions: Diabetes Mellitus, Type I
    View official trial listing →
  • Completed NCT NCT00122447

    Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance

    Not yet reported Emory University 84 participants Est. completion 2011-05 2 sites
    Prediabetes Other conditions: Prediabetic State
    View official trial listing →
  • Completed NCT NCT00125645

    Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study)

    Not yet reported University of Southern Denmark 200 participants Est. completion 2011-09-01 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00129233

    Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance

    Not yet reported Nagoya University 1150 participants Est. completion 2013-04 1 site
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00130156

    Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension

    Not yet reported Eisai Inc. 93 participants Est. completion 2009-03 1 site
    Other conditions: High Blood Pressure
    View official trial listing →
  • Completed NCT NCT00135551

    Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients

    Not yet reported Seiji Umemoto, M.D., Ph.D. 3501 participants Est. completion 2010-11 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00141453

    ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial

    Not yet reported Daiichi Sankyo Co., Ltd. 577 participants Est. completion 2009-01 2 sites
    Chronic kidney diseaseType 2 diabetes Other conditions: Proteinuria
    View official trial listing →
  • Terminated NCT NCT00141583

    The Renin-Angiotensin System in Essential Hypertension

    Not yet reported St George's, University of London 11 participants Est. completion 2006-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00144144

    A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 Diabetes

    Not yet reported Advanced-J 300 participants Est. completion 2008-09 1 site
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00150826

    QWISE - Study of Quinapril in Women With Chest Pain, Coronary Flow Reserve Limitations and Evidence of Myocardial Ischemia

    Not yet reported University of Florida 78 participants Est. completion 2004-12 1 site
    Other conditions: Ischemic Heart Disease
    View official trial listing →
  • Completed NCT NCT00153101

    Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

    Not yet reported Boehringer Ingelheim 31546 participants 732 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00155064

    Kallikrein-kinin (KKS) and Renin-angiotensin-aldosterone System (RAAS) in Primary Aldosteronism

    Not yet reported National Taiwan University Hospital 100 participants Est. completion 2005-12 1 site
    Other conditions: Hyperaldosteronism
    View official trial listing →
  • Completed NCT NCT00155246

    Efficacy of Pentoxifylline on Chronic Kidney Disease

    Not yet reported National Taiwan University Hospital 60 participants Est. completion 2007-01 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00155779

    ACE Gene Polymorphism and ARDS Outcome

    National Taiwan University Hospital 250 participants Est. completion 2004-12 1 site
    Other conditions: Adult Respiratory Distress Syndrome
    View official trial listing →
  • Completed NCT NCT00170924

    To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.

    Not yet reported Novartis 317 participants Est. completion 2006-06 1 site
    Other conditions: Diastolic Dysfunction, Hypertension
    View official trial listing →
  • Completed NCT NCT00172276

    Angiotensin Converting Enzyme Gene Polymorphism in Children With Idiopathic Nephrotic Syndrome

    National Taiwan University Hospital
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Completed NCT NCT00180024

    Characterization of Vascular Effects of Angiotensin II in Dorsal Human Hand Veins.

    Not yet reported Technische Universität Dresden Est. completion 2005-09 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT00184587

    Prophylactic Treatment of Episodic Cluster Headache

    Not yet reported Norwegian University of Science and Technology 40 participants Est. completion 2009-12 1 site
    Other conditions: Cluster Headache
    View official trial listing →
  • Completed NCT NCT00185120

    Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker

    Not yet reported Daiichi Sankyo 152 participants Est. completion 2006-09 20 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00190580

    Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease

    Not yet reported KVT-Study Group 312 participants Est. completion 2008-04 1 site Stand-alone
    Chronic kidney disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00199927

    Statins in Proteinuric Nephropathies

    Not yet reported Mario Negri Institute for Pharmacological Research 217 participants Est. completion 2008-03 16 sites
    Other conditions: Chronic Nephropathy, Proteinuria, Hypertension
    View official trial listing →
  • Status unknown NCT NCT00202618

    Rationale and Design for Shiga Microalbuminuria Reduction Trial

    Not yet reported Shiga University 160 participants Est. completion 2006-06 1 site
    Other conditions: Hypertension, Diabetes Mellitus, Albuminuria
    View official trial listing →
  • Completed NCT NCT00208767

    Effect of Valsartan on Carotid Artery Disease

    Not yet reported Emory University 120 participants Est. completion 2009-11 1 site
    Other conditions: Carotid Artery Diseases, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00221533

    Relation Between Renin-Angiotensin Gene Polymorphisms, Plasma Adiponectin and Arterial Stiffness in Renal Transplant Recipients

    University Hospital, Ghent 250 participants Est. completion 2006-08 1 site
    Other conditions: Vascular Diseases, Arterial Stiffness
    View official trial listing →
  • Status unknown NCT NCT00225667

    Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers

    Not yet reported Connolly, Stuart, M.D. 200 participants Est. completion 2007-07 1 site
    Other conditions: Atrial Fibrillation, Hypertension
    View official trial listing →
  • Completed NCT NCT00232882

    Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.

    Not yet reported Institut de Recherches Cliniques de Montreal 86 participants Est. completion 2006-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00235287

    Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease

    Not yet reported Herlev Hospital 60 participants 1 site
    Cardiovascular disease Other conditions: Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT00240019

    Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease.

    Not yet reported Stanford University 30 participants Est. completion 2006-04 2 sites
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00241904

    Reducing Total Cardiovascular Risk in an Urban Community

    Not yet reported Johns Hopkins University 525 participants Est. completion 2010-05 1 site
    Cardiovascular disease Other conditions: Heart Diseases, Coronary Disease, Diabetes Mellitus, Atherosclerosis, Cerebral Arteriosclerosis, Hypertension
    View official trial listing →
  • Completed NCT NCT00248807

    A Study of Blood Pressure and Blood Supply to the Brain in Persons With a Spinal Cord Injury.

    Not yet reported VA Office of Research and Development 30 participants Est. completion 2012-04 1 site
    Other conditions: Orthostatic Hypotension, Spinal Cord Injuries
    View official trial listing →
  • Completed NCT NCT00250562

    A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.

    Not yet reported Novartis 1171 participants Est. completion 2006-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00263393

    Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)

    Not yet reported The George Institute 3712 participants Est. completion 2009-06 1 site
    Cardiovascular disease Other conditions: Angina Pectoris, Cerebrovascular Accidents, Diabetes Mellitus
    View official trial listing →
  • Withdrawn NCT NCT00280215

    Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria

    Not yet reported Mayo Clinic Est. completion 2011-12
    Other conditions: Hyperoxaluria
    View official trial listing →
  • Completed NCT NCT00283686

    HALT Progression of Polycystic Kidney Disease Study A

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 558 participants Est. completion 2014-06 7 sites
    Other conditions: Kidney, Polycystic
    View official trial listing →
  • Completed NCT NCT00292162

    Curing Atrial Fibrillation in Heart Failure

    Not yet reported NHS Greater Glasgow and Clyde 41 participants Est. completion 2009-07 1 site
    Heart failure Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00310778

    Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-Blocker

    Not yet reported Assistance Publique - Hôpitaux de Paris 64 participants Est. completion 2007-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT00318474

    Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy

    Not yet reported St. Joseph's Hospital and Medical Center, Phoenix 184 participants Est. completion 2010-03 1 site
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Terminated NCT NCT00319202

    Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese Subjects

    Not yet reported Fundación Cardiovascular de Colombia 56 participants Est. completion 2012-02 1 site
    Other conditions: Glucose Intolerance, Obesity
    View official trial listing →
  • Completed NCT NCT00320879

    Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria

    Not yet reported Steno Diabetes Center Copenhagen 52 participants Est. completion 2004-11 1 site
    Type 2 diabetes Other conditions: Microalbuminuria
    View official trial listing →
  • Completed NCT NCT00321945

    A Retrospective Analysis of the Use of ACE-inhibitors and Angiotensin Receptor Blockers

    Emory University 546 participants Est. completion 2009-10 3 sites
    Other conditions: Atrial Fibrillation, Atrial Flutter
    View official trial listing →
  • Completed NCT NCT00344513

    Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF)

    Not yet reported GlaxoSmithKline 50000 participants Est. completion 2005-06-30
    Heart failure
    View official trial listing →
  • Completed NCT NCT00347087

    Effect of Irbesartan on Insulin Sensitivity in Chronic Heart Failure

    Not yet reported Charite University, Berlin, Germany 36 participants Est. completion 2007-06 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00355589

    Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension

    Not yet reported Pfizer Est. completion 2007-03 60 sites
    Other conditions: Hypertension, Blood Pressure, High
    View official trial listing →
  • Completed NCT NCT00361023

    Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy

    Not yet reported Shanghai Jiao Tong University School of Medicine 25 participants Est. completion 2006-07
    Type 2 diabetesChronic kidney disease
    View official trial listing →
  • Suspended NCT NCT00369538

    Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria

    Not yet reported University Hospital, Strasbourg, France 20 participants 1 site
    Other conditions: Proteinuria, Hypertension, End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00376272

    GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence

    Not yet reported Gruppo di Ricerca GISSI 1442 participants Est. completion 2008-03 114 sites
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00389168

    Irbesartan and Atenolol in Hypertensive Heart Disease

    Not yet reported, Not yet reported Karolinska Institutet 115 participants Est. completion 1997-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00395005

    Correlation of Urinary Kallikrein With Cytokines, Proteinuria and Renal Function in Chronic Renal Disease Patients

    National Taiwan University Hospital 50 participants Est. completion 2006-10
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00417222

    Supplemental Benefit of Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan

    Not yet reported Tohoku University 1145 participants Est. completion 2013-12 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00437463

    Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor

    Not yet reported Sanofi 60 participants Est. completion 2010-09 1 site
    Other conditions: Glomerulonephritis
    View official trial listing →
  • Suspended NCT NCT00438412

    Vasoactive Hormones and Oxygen Saturation During Apneic Events in Patients With Obstructive Sleep Apnea

    Regional Hospital Holstebro 40 participants 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT00446862

    The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study

    University of Alabama at Birmingham 36 participants Est. completion 2012-12 6 sites
    Other conditions: Fabry Disease, Proteinuria
    View official trial listing →
  • Completed NCT NCT00459771

    Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity

    Not yet reported The Netherlands Cancer Institute 210 participants Est. completion 2014-12 19 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00471562

    Angiotensin-(1-7) in Treating Patients With Metastatic or Unresectable Solid Tumors

    Not yet reported Wake Forest University Health Sciences 18 participants Est. completion 2009-10 1 site
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Terminated NCT NCT00498433

    Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension

    Not yet reported Novartis 46 participants Est. completion 2012-03 2 sites
    Other conditions: Hypertension, Abdominal Obesity
    View official trial listing →
  • Completed NCT NCT00498472

    NT-proBNP in the Optimization of Treatment After Recent Acute Heart Failure Trial

    Not yet reported Università degli Studi di Brescia 330 participants Est. completion 2010-04 1 site
    Heart failure
    View official trial listing →
  • Terminated NCT NCT00512369

    Effects of PA-1 Transcriptional Regulation on Monocyte Function

    Vanderbilt University 125 participants Est. completion 2011-07 1 site
    Other conditions: Atherosclerosis
    View official trial listing →
  • Terminated NCT NCT00517582

    Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema

    Not yet reported Vanderbilt University 13 participants Est. completion 2015-12 1 site
    Other conditions: Angioneurotic Edema
    View official trial listing →
  • Completed NCT NCT00519870

    Losartan Therapy in Pulmonary Hypertension

    Not yet reported Baskent University Est. completion 2005-07
    Other conditions: Pulmonary Hypertension
    View official trial listing →
  • Completed NCT NCT00523744

    Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension

    Not yet reported Novartis 257 participants Est. completion 2007-12 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00527514

    Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension

    Not yet reported Daiichi Sankyo 185 participants Est. completion 2008-04 18 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00529750

    Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With Hypertension

    Not yet reported Sanofi 108 participants Est. completion 2005-01
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00530595

    Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients

    Not yet reported Saitama Medical University
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT00555217

    VA NEPHRON-D: Diabetes iN Nephropathy Study

    Not yet reported US Department of Veterans Affairs 1448 participants Est. completion 2014-10 31 sites Stand-alone
    Type 2 diabetes Other conditions: Kidney Disease, Nephropathy
    View official trial listing →
  • Terminated NCT NCT00559286

    Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels

    Not yet reported RWTH Aachen University 40 participants Est. completion 2009-01 1 site
    Type 2 diabetes Other conditions: Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT00566774

    A Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies

    Not yet reported Brigham and Women's Hospital 5860 participants Est. completion 2010-11 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT00582114

    Hypertension in Hemodialysis Patients (Aim 3)

    Not yet reported Indiana University 200 participants Est. completion 2013-09 1 site Stand-alone
    Other conditions: Hemodialysis, Hypertension, Left Ventricular Hypertrophy
    View official trial listing →
  • Terminated NCT NCT00630708

    Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency

    Not yet reported Nanfang Hospital, Southern Medical University 309 participants Est. completion 2014-03 1 site
    Other conditions: Renal Insufficiency, Chronic
    View official trial listing →
  • Terminated NCT NCT00638131

    Bosentan Use in Patients With Diabetic Nephropathy

    Not yet reported Centre hospitalier de l'Université de Montréal (CHUM) 1 participants Est. completion 2010-06 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00663377

    Effects of Losartan on Insulin Resistance in Patients With Heart Failure

    Not yet reported Tottori University Hospital 16 participants Est. completion 2007-03
    Heart failure
    View official trial listing →
  • Completed NCT NCT00670787

    Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial

    Not yet reported Kyushu University 207 participants Est. completion 2011-02 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00672451

    Rhubarb and Angiotensin Converting Enzyme Inhibitor

    Not yet reported Wake Forest University 8 participants Est. completion 2009-05 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00679237

    Risk Reduction in Coronary Heart Disease

    Not yet reported Sorlandet Hospital HF 1600 participants Est. completion 2019-12 1 site
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00685945

    Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3

    Not yet reported Vanderbilt University 24 participants Est. completion 2009-01 1 site
    Other conditions: Obesity
    View official trial listing →
  • Terminated NCT NCT00702221

    Safety and Efficacy Study of Angiotensin Therapeutic Vaccine in Subjects With Mild to Moderate Hypertension

    Not yet reported BTG International Inc. 20 participants Est. completion 2010-09 12 sites Stand-alone
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00710372

    Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension

    Not yet reported Cytos Biotechnology AG 83 participants Est. completion 2010-11 1 site
    Other conditions: Mild Essential Hypertension, Moderate Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00720226

    Efficacy of Losartan in Preventing Progression of COPD

    Not yet reported Johns Hopkins University 106 participants Est. completion 2016-08 1 site
    Other conditions: COPD, Emphysema, Chronic Bronchitis, Smoking
    View official trial listing →
  • Terminated NCT NCT00729365

    PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease)

    Not yet reported Northwestern University 65 participants Est. completion 2010-06 6 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00732069

    Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis

    Not yet reported Vanderbilt University 19 participants Est. completion 2011-12 1 site
    Other conditions: End Stage Renal Failure on Dialysis, Complication of Hemodialysis
    View official trial listing →
  • Status unknown NCT NCT00734123

    Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.

    Not yet reported Hospital Arnau de Vilanova 2948 participants Est. completion 2013-05 1 site
    Cardiovascular disease Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00741156

    The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution

    Not yet reported The Hospital for Sick Children 12 participants Est. completion 2010-01 1 site
    Other conditions: Hypertension, Congestive Cardiomyopathy
    View official trial listing →
  • Withdrawn NCT NCT00745953

    Regression of Fatty Heart by Valsartan Therapy

    Not yet reported University of Texas Southwestern Medical Center Est. completion 2009-08 1 site
    Metabolic syndrome Other conditions: Lipotoxicity
    View official trial listing →
  • Completed NCT NCT00750308

    Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i

    Not yet reported Vanderbilt University 27 participants Est. completion 2009-05
    Metabolic syndrome
    View official trial listing →
  • Terminated NCT NCT00757250

    Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy

    Not yet reported US Biotest, Inc. 13 participants Est. completion 2011-12 3 sites Stand-alone
    Other conditions: HIV Infections
    View official trial listing →
  • Terminated NCT NCT00763893

    Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome

    Not yet reported Assistance Publique - Hôpitaux de Paris 303 participants Est. completion 2014-12 1 site
    Other conditions: Marfan Syndrome
    View official trial listing →
  • Completed NCT NCT00775840

    Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.

    Not yet reported Takeda 22 participants Est. completion 2008-12 37 sites Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT00819845

    Ramipril Versus Carvedilol in Duchenne and Becker Patients

    Not yet reported Catholic University, Italy 194 participants Est. completion 2016-12 1 site
    Other conditions: Duchenne Muscular Dystrophy, Becker Muscular Dystrophy
    View official trial listing →
  • Completed NCT NCT00834600

    Renin Profiling in Selection of Initial Antihypertensive Drug

    Not yet reported The Louis & Rachel Rudin Foundation 185 participants Est. completion 2011-10 5 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00853658

    Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure

    Not yet reported Novartis Pharmaceuticals 7064 participants Est. completion 2015-10 806 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT00853827

    Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients

    Not yet reported Novartis Pharmaceuticals 613 participants Est. completion 2013-01 129 sites
    Cardiovascular disease Other conditions: Coronary Atherosclerosis
    View official trial listing →
  • Status unknown NCT NCT00854763

    Olmesartan on Ambulatory Blood Pressure Change

    National Taiwan University Hospital 100 participants 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00866879

    Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients

    Not yet reported Northwestern University 275 participants Est. completion 2019-03 1 site Stand-alone
    Other conditions: Renal Transplant Rejection
    View official trial listing →
  • Completed NCT NCT00874432

    Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease

    Not yet reported University of Wisconsin, Madison 43 participants Est. completion 2011-12 1 site
    Cardiovascular diseaseChronic kidney disease
    View official trial listing →
  • Terminated NCT NCT00878969

    Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3

    Not yet reported Vanderbilt University 78 participants Est. completion 2015-06 1 site
    Other conditions: Oxidative Stress, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT00890591

    Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension

    Not yet reported Daiichi Sankyo 144 participants Est. completion 2007-08
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00893425

    Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria

    Not yet reported Gulhane School of Medicine 78 participants Est. completion 2009-04 1 site
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT00901719

    Investigating Systemic and Local Vascular Responses to Apelin in the Context of Renin-angiotensin Upregulation

    Not yet reported University of Edinburgh 12 participants Est. completion 2010-05 1 site Stand-alone
    Heart failure Other conditions: Heart Disease, Vasodilatation
    View official trial listing →
  • Completed NCT NCT00901745

    Interaction of Apelin and Angiotensin in the Human Forearm Circulation

    Not yet reported University of Edinburgh 12 participants Est. completion 2010-04 1 site Stand-alone
    Other conditions: Heart Disease, Vasodilation
    View official trial listing →
  • Terminated NCT NCT00913393

    Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy

    Not yet reported Kyntra Bio 46 participants Est. completion 2010-06 28 sites
    Type 2 diabetesChronic kidney disease
    View official trial listing →
  • Completed NCT NCT00914524

    Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy

    Not yet reported Daiichi Sankyo Co., Ltd. 49 participants Est. completion 2006-10 1 site
    Chronic kidney disease Other conditions: Chronic Glomerulonephritis
    View official trial listing →
  • Terminated NCT NCT00915928

    Chronic Subdural Hematoma - Reduction of Recurrence by Treatment With Angiotensin Converting Enzyme Inhibitors

    Not yet reported Odense University Hospital 47 participants Est. completion 2012-06
    Other conditions: Hematoma, Subdural, Chronic
    View official trial listing →
  • Completed NCT NCT00923156

    Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure

    Not yet reported Novartis Pharmaceuticals 123 participants Est. completion 2011-02 16 sites
    Heart failure
    View official trial listing →
  • Withdrawn NCT NCT00930995

    Angiotensin Receptor Blockade as an Anti-Fibrotic Intervention in Patients With Chronic Hepatitis C

    Not yet reported Kaiser Permanente 2 sites
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT00933231

    Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

    Not yet reported Astellas Pharma Inc 281 participants Est. completion 2018-04-03 13 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00939588

    Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients

    Not yet reported Novartis Pharmaceuticals 88 participants 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00962949

    The Renin-Aldosterone Axis in Postural Tachycardia Syndrome

    Not yet reported Vanderbilt University Medical Center 28 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Postural Orthostatic Tachycardia Syndrome (POTS)
    View official trial listing →
  • Terminated NCT NCT00968383

    Cardiovascular Magnetic Resonance for the Occluded Infarct-Related Artery Treatment

    Not yet reported National Institute of Cardiology, Warsaw, Poland 11 participants Est. completion 2012-12 1 site Stand-alone
    Cardiovascular diseaseHeart failure Other conditions: Heart Diseases
    View official trial listing →
  • Completed NCT NCT00985322

    Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis

    Not yet reported Mario Negri Institute for Pharmacological Research 269 participants Est. completion 2016-04 29 sites
    Other conditions: Left Ventricular Hypertrophy, Hypertension
    View official trial listing →
  • Completed NCT NCT00990639

    Effect of Candesartan in Alcoholic Liver Fibrosis

    Not yet reported, Not yet reported Yonsei University 85 participants Est. completion 2009-03 1 site
    Other conditions: Alcoholic Liver Disease
    View official trial listing →
  • Withdrawn NCT NCT00994253

    Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II Diabetics

    Not yet reported Corewell Health East Est. completion 2012-12 1 site
    Other conditions: Hypertension, Diabetes Type 2
    View official trial listing →
  • Withdrawn NCT NCT01009944

    Genetic Mechanisms in Human Hypertension Renin-angiotensin-aldosterone System (RAAS) Inhibition Study

    Not yet reported Brigham and Women's Hospital Est. completion 2019-03-19 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01011660

    Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients

    Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 13542 participants Est. completion 2012-12 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01014338

    Angiotensin-converting Enzyme (ACE)-Inhibition and Mechanisms of Skeletal Muscle Weakness in Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Imperial College London 80 participants Est. completion 2012-09 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01015937

    Effect of Turmeric on Diabetic Nephropathy

    Not yet reported Shaheed Faghihi Hospital 50 participants Est. completion 2009-08 1 site
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT01024543

    Role of Angiotensin II in Insulin-induced Microvascular Activity

    Not yet reported Maastricht University Medical Center 18 participants Est. completion 2009-11 1 site Stand-alone
    Other conditions: Insulin Sensitivity, Microcirculation
    View official trial listing →
  • Completed NCT NCT01028534

    Effects of Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea (OSA)

    Not yet reported Kyoto University, Graduate School of Medicine 150 participants Est. completion 2013-12 2 sites
    Obstructive sleep apnea Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01053026

    Evaluation of Effects of Exercise Training and ARB in DM Patients

    National Taiwan University Hospital 15 participants Est. completion 2011-12 1 site
    Other conditions: Vascular Function, Exercise Training
    View official trial listing →
  • Completed NCT NCT01066572

    Paramedic Initiated Lisinopril For Acute Stroke Treatment

    Not yet reported Newcastle-upon-Tyne Hospitals NHS Trust 14 participants Est. completion 2011-12 4 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01071642

    The Influence of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Renal Function in Patients Undergoing Non-emergent Coronary Angiography

    Not yet reported Soroka University Medical Center 100 participants Est. completion 2010-11 1 site
    Other conditions: Blood Pressure
    View official trial listing →
  • Completed NCT NCT01071681

    Survey to Assess Why People Are Not Responding to Treatment in Hypertension

    Bayer 1589 participants Est. completion 2010-09 1 site
    Other conditions: Arterial Hypertension
    View official trial listing →
  • Withdrawn NCT NCT01089452

    Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure Study

    Not yet reported Monash University 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT01096121

    Angiotensin-converting Enzyme Inhibitors and Early Sickle Cell Renal Disease in Children

    Not yet reported Assistance Publique - Hôpitaux de Paris 5 participants Est. completion 2012-06 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Terminated NCT NCT01101269

    Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease

    Not yet reported University of Virginia 6 participants Est. completion 2014-12 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01113047

    Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine

    Not yet reported Novartis 347 participants 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01115426

    Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis

    Not yet reported University Magna Graecia 20 participants Est. completion 2008-01 1 site
    Other conditions: IGA Glomerulonephritis
    View official trial listing →
  • Terminated NCT NCT01132768

    The Confirmatory Olmesartan Plaque Regression Study

    Not yet reported Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 114 participants Est. completion 2011-06 1 site
    Other conditions: Essential Hypertension, Carotid Plaque
    View official trial listing →
  • Completed NCT NCT01152567

    Effects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension

    AstraZeneca 50000 participants Est. completion 2010-11 56 sites
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01154361

    AMelioration of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Study

    Not yet reported Technical University of Munich 1 site
    Other conditions: Angioedema
    View official trial listing →
  • Status unknown NCT NCT01162980

    The Angiotensin Converting Enzyme (ACE) Inhibitor SwitchBack Study

    McGill University Health Centre/Research Institute of the McGill University Health Centre 100 participants Est. completion 2012-07 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT01167920

    Virtual Hypertension Clinic

    Not yet reported The Cleveland Clinic 74 participants Est. completion 2014-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01173029

    Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events

    Universidade Gama Filho 92 participants Est. completion 2010-12 1 site
    Cardiovascular disease Other conditions: Systemic Arterial Hypertension, Hypertension Resistant to Conventional Therapy
    View official trial listing →
  • Completed NCT NCT01188304

    A Study of Aleglitazar in Combination With Aspirin in Healthy Volunteers

    Not yet reported Hoffmann-La Roche 44 participants Est. completion 2010-10 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01188317

    A Study of Aleglitazar in Combination With Ibuprofen in Healthy Volunteers

    Not yet reported Hoffmann-La Roche 44 participants Est. completion 2011-09 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01193101

    Efficacy and Safety of LCZ696 Compared to Placebo in Patients With Essential Hypertension

    Not yet reported Novartis Pharmaceuticals 389 participants Est. completion 2011-04 34 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01195662

    A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication

    Not yet reported AstraZeneca 2245 participants Est. completion 2013-02 298 sites
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT01202721

    Beta Blockers and Angiotensin Receptor Blockers in Bicuspid Aortic Valve Disease Aortopathy (BAV Study)

    Not yet reported Hamilton Health Sciences Corporation 85 participants Est. completion 2016-11 13 sites
    Other conditions: Cardiac Disease
    View official trial listing →
  • Completed NCT NCT01210430

    Local Vasoconstriction in Postural Tachycardia Syndrome

    Not yet reported New York Medical College 74 participants Est. completion 2015-06 1 site
    Other conditions: Postural Tachycardia Syndrome
    View official trial listing →
  • Completed NCT NCT01258764

    Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril

    Not yet reported Scripps Translational Science Institute 2 participants Est. completion 2014-03 1 site
    Other conditions: Hypertension, Grade 1, Hypertension Treatment, N of 1 Study Design, Hypertension
    View official trial listing →
  • Completed NCT NCT01281306

    An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension

    Not yet reported Novartis Pharmaceuticals 910 participants Est. completion 2011-12 90 sites
    Other conditions: Systolic Hypertension
    View official trial listing →
  • Completed NCT NCT01281787

    PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer

    Not yet reported European Institute of Oncology 320 participants Est. completion 2013-10 1 site
    Other conditions: Lung Cancer, Atrial Fibrillation
    View official trial listing →
  • Terminated NCT NCT01300611

    TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation

    Not yet reported Tarix Pharmaceuticals 20 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Myelofibrosis, Acute Lymphoblastic Leukemia, Chronic Myelocytic Leukemia, Non Hodgkins Lymphoma, Hodgkins Lymphoma, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Status unknown NCT NCT01305850

    The Effect of Aliskiren and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients

    Not yet reported Chulalongkorn University 100 participants Est. completion 2011-10 1 site
    Other conditions: Peritoneal Membrane Failure
    View official trial listing →
  • Completed NCT NCT01312714

    Vitamin D3 Supplementation in Dialysis Patients

    Not yet reported Regional Hospital Holstebro 64 participants Est. completion 2012-09 1 site
    Other conditions: End-Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT01320722

    Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function

    Not yet reported Brigham and Women's Hospital 242 participants Est. completion 2015-06 1 site
    Other conditions: Renal Function, Endothelial Function, Blood Pressure, Overweight, Obesity
    View official trial listing →
  • Completed NCT NCT01324245

    Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt Diet

    Not yet reported Georgetown University 45 participants Est. completion 2006-05 1 site
    Other conditions: Salt-sensitive Hypertension
    View official trial listing →
  • Completed NCT NCT01328769

    Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)

    Not yet reported Paul N. Hopkins 49 participants Est. completion 2014-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01340326

    The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling

    Not yet reported Dong-A University 800 participants Est. completion 2014-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT01377285

    Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)

    Not yet reported National Taiwan University Hospital 350 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Chronic Renal Failure
    View official trial listing →
  • Completed NCT NCT01393782

    Intravenous AII for the Treatment of Severe Hypotension in High Output Shock: A Pilot Study

    Not yet reported George Washington University 20 participants Est. completion 2014-01 1 site
    Other conditions: Septic Shock
    View official trial listing →
  • Completed NCT NCT01407627

    Evaluation of Fructose Ingestion and the Renin Angiotensin System in Humans

    Not yet reported University of Calgary 64 participants Est. completion 2021-05 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT01411371

    Catheter Ablation Versus Medical Treatment of AF in Heart Failure

    Not yet reported Barts & The London NHS Trust 50 participants Est. completion 2013-02 1 site
    Heart failure Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT01425411

    Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy

    Not yet reported Mustafa Kemal University 38 participants Est. completion 2008-11 1 site
    Other conditions: Hypertension, Left Ventricular Hypertrophy
    View official trial listing →
  • Active, not recruiting NCT NCT01426529

    Caveolin-1 and Vascular Dysfunction

    Not yet reported Brigham and Women's Hospital 120 participants Est. completion 2026-10-15 1 site Stand-alone
    Other conditions: Hypertension, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT01437371

    Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients?

    Not yet reported University Hospital, Clermont-Ferrand 35 participants Est. completion 2014-06 1 site
    Heart failure
    View official trial listing →
  • Terminated NCT NCT01456208

    Genetic Mechanisms in Human Hypertension

    Brigham and Women's Hospital 150 participants Est. completion 2020-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01471860

    BAROSTIM NEO System in the Treatment of Heart Failure

    Not yet reported CVRx, Inc. 94 participants Est. completion 2021-08-11 30 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT01483781

    A Study of the Effects of Canagliflozin on Plasma Volume in Patients With Type 2 Diabetes Mellitus

    Not yet reported Janssen Research & Development, LLC 36 participants Est. completion 2012-08 1 site
    Type 2 diabetes Other conditions: Plasma Volume
    View official trial listing →
  • Status unknown NCT NCT01500590

    Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria

    Not yet reported Hospital Authority, Hong Kong 1400 participants Est. completion 2019-08 1 site Stand-alone
    Other conditions: Diabetes, Hypertensive Disease
    View official trial listing →
  • Terminated NCT NCT01511263

    Epigallocatechingallate (EGCG) in Cardiac AL Amyloidosis

    Not yet reported Fondazione IRCCS Policlinico San Matteo di Pavia 86 participants Est. completion 2016-07 1 site
    Other conditions: Primary Amyloidosis of Light Chain Type
    View official trial listing →
  • Completed NCT NCT01525888

    Renin-angiotensin-aldosterone System (RAAS) Blockade and Contrast Induced Nephropathy

    Not yet reported Soroka University Medical Center 100 participants Est. completion 2013-12 Stand-alone
    Other conditions: Radiographic Contrast Agent Nephropathy
    View official trial listing →
  • Completed NCT NCT01545479

    Increased Renal Oxygenation and Angiotensin Converting Enzyme Inhibition

    Not yet reported Instituto de Cardiologia do Rio Grande do Sul 5 participants Est. completion 2010-12
    Other conditions: Renal Disease
    View official trial listing →
  • Completed NCT NCT01553539

    Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery

    Not yet reported Wake Forest University Health Sciences 20 participants Est. completion 2013-01 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Bone Cancer, Clear Cell Sarcoma of the Kidney, Ovarian Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Uterine Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage III Uterine Sarcoma, Stage IV Adult Soft Tissue Sarcoma, Stage IV Uterine Sarcoma
    View official trial listing →
  • Withdrawn NCT NCT01554254

    Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation

    Not yet reported Tarix Pharmaceuticals 1 site
    Other conditions: Cord Blood Transplant, Hematologic Malignancy, Inherited Metabolic Disease
    View official trial listing →
  • Completed NCT NCT01563731

    Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives

    Not yet reported Istituto Auxologico Italiano 200 participants Est. completion 2021-03-31 1 site
    Cardiovascular disease Other conditions: Transient Ischemic Attack, Hypertension
    View official trial listing →
  • Completed NCT NCT01575652

    Effects of Aceis on Peritoneal Protein Loss and Solute Transport in pd Patients

    Not yet reported Turkish Nephrology Association 43 participants Est. completion 2009-01
    Other conditions: Disorders Associated With Peritoneal Dialysis
    View official trial listing →
  • Completed NCT NCT01588795

    Renal Denervation in Diabetic Nephropathy

    Not yet reported Assistance Publique - Hôpitaux de Paris 25 participants Est. completion 2016-01 1 site
    Chronic kidney disease Other conditions: Persistent Proteinuria With Type II Diabetes
    View official trial listing →
  • Status unknown NCT NCT01589380

    A Randomized Trial of Angiotensin Receptor bLocker,Fimasartan, in Aortic Stenosis (ALFA Trial)

    Not yet reported Seoul National University Hospital 100 participants Est. completion 2014-12 7 sites
    Other conditions: Critical Stenosis of Aortic Valve
    View official trial listing →
  • Status unknown NCT NCT01624064

    Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology

    Not yet reported, Not yet reported Ministry of Health, Sri Lanka 200 participants Est. completion 2013-10 1 site
    Other conditions: Renal Insufficiency, Chronic
    View official trial listing →
  • Completed NCT NCT01635192

    Effects of Probiotic VSL#3 on Expression of Small Intestinal Renin-angiotensin System

    Not yet reported Göteborg University 24 participants Est. completion 2013-07 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Status unknown NCT NCT01665235

    Blood Pressure Variability and the Prognosis of Ischemic Stroke With Intracranial Artery Stenosis

    Not yet reported RenJi Hospital 200 participants Est. completion 2014-08 1 site
    Other conditions: Blood Pressure Variability, Intracranial Artery Stenosis
    View official trial listing →
  • Completed NCT NCT01669434

    Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery

    Not yet reported University of Nebraska 291 participants Est. completion 2016-12-01 1 site Stand-alone
    Other conditions: Hypotension on Induction
    View official trial listing →
  • Completed NCT NCT01669928

    Anti-hypertensive Medication Dosing Regimen in Effective Blood Pressure Control

    Not yet reported Imperial College London 103 participants Est. completion 2015-07 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01670903

    The Effect of Angiotensin II Type 1 Receptor Antagonists on the Size and Expansion Rate of Abdominal Aortas in Hypertensive Patients

    Sheba Medical Center 150 participants 2 sites
    Other conditions: Aneurysm, Hypertension
    View official trial listing →
  • Completed NCT NCT01675362

    Are There Protective Effects of Antioxidants, Calcium Channel Blocker and Angiotensin Receptor Blocker Against Extracorporeal Shockwaves Lithotripsy Induced Renal Injury?

    Not yet reported Mansoura University 160 participants Est. completion 2014-10 1 site
    Other conditions: Kidney Calculi
    View official trial listing →
  • Completed NCT NCT01682577

    Bioequivalence Study of Two Formulations of Perindopril 4 mg Tablet Under Fasting Condition

    Not yet reported Dexa Medica Group 18 participants Est. completion 2008-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01684748

    Angiotensin II Blockade and Inflammation in Obesity

    Not yet reported Virginia Polytechnic Institute and State University 20 participants Est. completion 2011-08
    Other conditions: Overweight, Obese, Prehypertension, Hypertension
    View official trial listing →
  • Completed NCT NCT01691118

    A Trial of Fimasartan for Early Diastolic Heart Failure

    Not yet reported Asan Medical Center 60 participants Est. completion 2015-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01691781

    The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study

    Not yet reported Brigham and Women's Hospital 41 participants Est. completion 2016-12 1 site
    Other conditions: Hyperparathyroidism
    View official trial listing →
  • Completed NCT NCT01692795

    Cardiovascular Medication Use Before First Myocardial Infarction

    London School of Hygiene and Tropical Medicine 17000 participants Est. completion 2013-09 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT01715584

    Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 80 participants Est. completion 2019-12-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01716819

    Role of the Renin Angiotensin Aldosterone System in the Mechanisms of Transition to Heart Failure in Abdominal Obesity

    Not yet reported Central Hospital, Nancy, France 101 participants Est. completion 2015-03 1 site
    Other conditions: Obesity, Abdominal
    View official trial listing →
  • Completed NCT NCT01734096

    Renal Response to Lower Body Negative Pressure in Pre-hypertensive States

    Not yet reported PD Dr. Grégoire Wuerzner 78 participants Est. completion 2016-04 2 sites
    Other conditions: Hypertension, Obesity, White Coat Hypertension, Resistant Hypertension
    View official trial listing →
  • Terminated NCT NCT01752985

    Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease

    Not yet reported Bristol-Myers Squibb 319 participants Est. completion 2015-06-30 62 sites
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT01771783

    RAS-Peptide-Profile Study in Healthy Male Subjects

    Not yet reported University Hospital, Basel, Switzerland 12 participants 1 site Stand-alone
    Other conditions: RAS Peptide Profile in Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01792518

    MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin

    Not yet reported Boehringer Ingelheim 360 participants Est. completion 2015-12 74 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01808196

    Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD

    Not yet reported Children's Hospital Medical Center, Cincinnati 6 participants Est. completion 2015-02-13 1 site
    Other conditions: Eosinophilic Esophagitis, Connective Tissue Disorders
    View official trial listing →
  • Completed NCT NCT01821053

    Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes Mellitus

    Odense University Hospital 85 participants Est. completion 2015-10 1 site
    Other conditions: Preeclampsia, Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT01829126

    Development and Prevention of Severe Heart Disease in Systemic Sclerosis

    Gabriele Valentini 765 participants Est. completion 2016-08 11 sites
    Heart failure Other conditions: Systemic Sclerosis, Cardiac Diseases, Heart Block, Cardiac Arrhythmia
    View official trial listing →
  • Completed NCT NCT01830530

    HIGH Altitude CArdiovascular REsearch in the ANDES

    Not yet reported Istituto Auxologico Italiano 100 participants Est. completion 2012-10 1 site
    Other conditions: Hypertension, High Altitude
    View official trial listing →
  • Completed NCT NCT01840072

    China Antihypertensive Trial in Acute Ischemic Stroke

    Not yet reported Tulane University 4071 participants Est. completion 2016-05 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT01856361

    Ramipril for the Treatment of Oligospermia

    Not yet reported Weill Medical College of Cornell University 2 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: Oligospermia, Teratospermia, Asthenozoospermia, Male Infertility
    View official trial listing →
  • Completed NCT NCT01857999

    Losartan in Decompensated Heart Failure

    Not yet reported InCor Heart Institute 21 participants Est. completion 2011-03 1 site
    Heart failure Other conditions: Low Cardiac Output
    View official trial listing →
  • Completed NCT NCT01885559

    HALT Progression of Polycystic Kidney Disease Study B

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 486 participants Est. completion 2014-06 7 sites
    Other conditions: Kidney, Polycystic
    View official trial listing →
  • Completed NCT NCT01904695

    Causal Inference Research of Resistant Hypertension Treatment With Chinese Approach in a Cohort Study

    Not yet reported China Academy of Chinese Medical Sciences 192 participants Est. completion 2015-12 1 site
    Other conditions: Primary Hypertension, Hypertension, Resistant to Conventional Therapy
    View official trial listing →
  • Completed NCT NCT01919801

    Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema

    Not yet reported Shire 118 participants Est. completion 2015-08-22 55 sites
    Other conditions: Angiotensin Converting Enzyme Inhibitor Induced Angioedema
    View official trial listing →
  • Completed NCT NCT01920815

    Bicuspid Valve Aortopathy Feasibility Study

    Oregon Health and Science University 500 participants Est. completion 2017-10-04 6 sites
    Other conditions: Bicuspid Aortic Valve
    View official trial listing →
  • Completed NCT NCT01936012

    Bioequivalence Study of Two Formulations of 10 mg Lisinopril Tablet Under Fasting Condition

    Not yet reported Dexa Medica Group 34 participants Est. completion 2013-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01938664

    A Pilot Study of Candesartan as a Treatment for Cocaine Dependence

    Not yet reported Baylor College of Medicine 30 participants Est. completion 2016-07 1 site
    Other conditions: Cocaine Dependence
    View official trial listing →
  • Withdrawn NCT NCT01948232

    Pilot Study of Perindopril in Childhood Cancer Survivors

    Not yet reported The Hospital for Sick Children Est. completion 2015-07 1 site Stand-alone
    Other conditions: Childhood Cancer Survivors
    View official trial listing →
  • Completed NCT NCT01963507

    Effects of a Resistance Training Period on Blood Pressure of Hypertensive Elderlies: Influence of the Polymorphism of the Angiotensin Converting Enzyme

    Not yet reported Federal University of São Paulo 136 participants Est. completion 2013-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01964079

    Comparision of Blood Pressure Variability Between Amlodipine and Losartan

    Not yet reported Wonju Severance Christian Hospital 144 participants Est. completion 2017-05 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT01983462

    Vascular Dysfunction in Human Obesity Hypertension

    Not yet reported Gary L. Pierce 33 participants Est. completion 2020-06 1 site
    Other conditions: Obesity, Prehypertension, Hypertension
    View official trial listing →
  • Status unknown NCT NCT01992796

    Angiotensin II Antagonist in Severe Sepsis

    Not yet reported University of Salerno 300 participants Est. completion 2017-01 1 site Stand-alone
    Other conditions: Severe Sepsis
    View official trial listing →
  • Terminated NCT NCT02007720

    Efficacy, Safety and Tolerability of Sexelaxin When Added to Standard Therapy in AHF

    Not yet reported Novartis Pharmaceuticals 876 participants Est. completion 2017-06-16 132 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT02008110

    Carbohydrate Antigen 125-guided Therapy in Heart Failure

    Not yet reported Fundación para la Investigación del Hospital Clínico de Valencia 360 participants Est. completion 2015-05 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT02010905

    Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone System

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 120 participants Est. completion 2018-01 6 sites
    Other conditions: Tetralogy of Fallot, Heart Defects, Congenital, Ventricular Dysfunction, Right
    View official trial listing →
  • Completed NCT NCT02096406

    Outcomes of Angiotensin Converting Enzyme Inhibitor Management Strategies Prior to Coronary Artery Bypass

    Not yet reported University of Alberta 126 participants Est. completion 2018-03 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02129725

    Effect of Prolonged PDE-5 Inhibition on Insulin Signaling in Skeletal Muscle.

    Not yet reported Vanderbilt University Medical Center 15 participants Est. completion 2016-12 1 site
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT02130687

    Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure

    Not yet reported Vanderbilt University 106 participants Est. completion 2020-08 1 site
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02170961

    Study of Polymorphisms of RAAS and MMPs in Acute Heart Failure

    University of Monastir 300 participants Est. completion 2016-12 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT02175355

    Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH)

    Not yet reported Boehringer Ingelheim 1039 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02184858

    Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension

    Not yet reported University Ghent 13 participants Est. completion 2018-09-17 1 site
    Other conditions: Primary Hypertension, Secondary Hypertension
    View official trial listing →
  • Completed NCT NCT02215733

    The Use of Angiotensin Receptor Blockers and the Risk of Cancer

    Boehringer Ingelheim 1165781 participants
    Other conditions: Neoplasm
    View official trial listing →
  • Completed NCT NCT02248896

    Antihypertensive Medications and the Risk of Sepsis

    Boehringer Ingelheim 1129062 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02265861

    Response of VEGF and AT-II to HCG in PCOS

    Not yet reported Nanjing University School of Medicine 60 participants Est. completion 2012-12
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT02294539

    Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients

    Not yet reported Chong-Jin Kim 231 participants Est. completion 2016-05-18 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02299388

    To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study

    Not yet reported Tulane University School of Medicine 11 participants Est. completion 2016-12 1 site
    Other conditions: Diabetes Mellitus, Non-Insulin-Dependent, Hypertensive Disease
    View official trial listing →
  • Completed NCT NCT02319590

    Anti-Angiotensin-Receptor 1 (ATR1)-, Anti-Endothelin-Receptor A (ETRA)-Antibodies and T Cells in Cardiomyopathy

    Zurich Regional Health Center 80 participants Est. completion 2020-12 1 site
    Other conditions: Cardiac Failure
    View official trial listing →
  • Completed NCT NCT02338843

    A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension

    Not yet reported La Jolla Pharmaceutical Company 344 participants Est. completion 2017-02-18 115 sites Stand-alone
    Other conditions: Catecholamine-resistant Hypotension (CRH), Distributive Shock, High Output Shock, Sepsis
    View official trial listing →
  • Completed NCT NCT02358096

    A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease

    Not yet reported Astellas Pharma Europe B.V. 125 participants Est. completion 2017-03-15 57 sites
    Chronic kidney diseaseType 2 diabetes
    View official trial listing →
  • Completed NCT NCT02373163

    INTERVENCION Trial

    Not yet reported Prevencion 166 participants Est. completion 2016-06-01 1 site
    Other conditions: Blood Pressure, High
    View official trial listing →
  • Completed NCT NCT02380157

    Blood Pressure Regulation - Role of Potassium

    Not yet reported Glostrup University Hospital, Copenhagen 25 participants Est. completion 2016-12 1 site
    Other conditions: Blood Pressure, Hypertension
    View official trial listing →
  • Status unknown NCT NCT02390193

    Effect of Hemodialysis on Upper Airways Collapsibility in Patients With Chronic Kidney Disease

    Not yet reported Centro Universitário de Anapolis 52 participants Est. completion 2020-12-03 1 site Stand-alone
    Other conditions: Renal Insufficiency, Chronic
    View official trial listing →
  • Completed NCT NCT02412761

    Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension

    Not yet reported The University of Texas Health Science Center, Houston 42 participants Est. completion 2016-07 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT02416024

    Arterial Stiffness and General Anesthesia Induced Hypotension in Patients on Angiotensin-converting Enzyme Inhibitors

    University of Iowa 72 participants Est. completion 2018-09 1 site
    Other conditions: Hypotension, Arterial Stiffness
    View official trial listing →
  • Completed NCT NCT02431936

    Effectiveness of Prazosin on the Urinary Sodium Excretion Response to Mental Stress

    Not yet reported Augusta University 50 participants Est. completion 2019-04-16 1 site
    Other conditions: Hypertension, Stress, Psychological, Blood Pressure
    View official trial listing →
  • Status unknown NCT NCT02432339

    Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress

    Not yet reported, Not yet reported Augusta University 50 participants Est. completion 2019-11-30 1 site
    Other conditions: Psychological Stress, Hypertension, Renal
    View official trial listing →
  • Completed NCT NCT02432885

    Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial

    Not yet reported InCor Heart Institute 76 participants Est. completion 2013-06
    Other conditions: Myocardial Fibrosis, Muscular Dystrophies
    View official trial listing →
  • Status unknown NCT NCT02499250

    Effect of Daily Remote Ischemic Conditioning on the Life Quality of Refractory Angina Pectoris Patients

    Not yet reported Navy General Hospital, Beijing 30 participants Est. completion 2017-01 1 site Stand-alone
    Other conditions: Refractory Angina Pectoris
    View official trial listing →
  • Status unknown NCT NCT02501772

    The Evaluation of Effect of Sanyinjiao (SP6) Acupressure on Early Diabetic Nephropathy

    Not yet reported Mackay Memorial Hospital 60 participants Est. completion 2019-12 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT02587936

    Improving Chronic Disease Management With Pieces

    Not yet reported University of Texas Southwestern Medical Center 18268 participants Est. completion 2022-10-15 4 sites Stand-alone
    Chronic kidney diseaseType 2 diabetes Other conditions: Diabetes, Hypertension, High BP
    View official trial listing →
  • Completed NCT NCT02596126

    Secondary Prevention of Cardiovascular Disease in the Elderly Trial

    Not yet reported Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III 2499 participants Est. completion 2022-03-31 113 sites
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT02606279

    Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients

    Not yet reported Wake Forest University Health Sciences 1 participants Est. completion 2016-08-04 1 site
    Other conditions: HIV, Aging, Sarcopenia, Angiotensin Receptor Antagonists
    View official trial listing →
  • Status unknown NCT NCT02623036

    The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors

    Not yet reported Memorial Health University Medical Center 20 participants Est. completion 2018-04 1 site
    Other conditions: Hypertension, Resistant to Conventional Therapy
    View official trial listing →
  • Completed NCT NCT02632747

    Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study

    Not yet reported Boehringer Ingelheim 31 participants Est. completion 2019-07-02 1 site
    Type 2 diabetes Other conditions: Diabetes Mellitus, Type 1, Obesity
    View official trial listing →
  • Withdrawn NCT NCT02649998

    Short-term Efficacy of Furosemide, Isosorbide Dinitrate and Their Combination in ADHF

    Not yet reported Chinese University of Hong Kong Est. completion 2022-06 1 site
    Other conditions: Heart Decompensation
    View official trial listing →
  • Status unknown NCT NCT02660866

    Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)

    Not yet reported North Texas Veterans Healthcare System 200 participants Est. completion 2019-07 12 sites
    Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Terminated NCT NCT02857309

    Cardiac Contractility Modulation (CCM) Therapy in Subjects With Medically Refractory Heart Failure

    Not yet reported Impulse Dynamics 50 participants Est. completion 2018-02-15 8 sites
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT02859311

    A Pilot Feasibility Study in Recovered Heart Failure

    Not yet reported Royal Brompton & Harefield NHS Foundation Trust 50 participants Est. completion 2018-08 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT02874794

    Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction

    Not yet reported Novartis Pharmaceuticals 465 participants Est. completion 2019-01-26 81 sites
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT02878018

    Cohort Study on Traditional Chinese Medicine Diagnosis and Treatment of Children With Henoch-Schonlein Purpura Nephritis

    Liaoning University of Traditional Chinese Medicine 600 participants Est. completion 2020-05 1 site
    Other conditions: Henoch-Schonlein Purpura Nephritis
    View official trial listing →
  • Completed NCT NCT02913664

    Risk Reduction for Alzheimer's Disease

    Not yet reported, Not yet reported University of Texas Southwestern Medical Center 513 participants Est. completion 2022-01-31 4 sites Stand-alone
    Other conditions: Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline, Family History of Alzheimer's Disease
    View official trial listing →
  • Withdrawn NCT NCT02985268

    Evaluation of Outcomes of CRT and MitraClip for Treatment of Low Ejection Fraction and Functional Mitral Regurgitation in HF

    Not yet reported Montreal Heart Institute Est. completion 2020-02
    Heart failure Other conditions: Functional Mitral Regurgitation
    View official trial listing →
  • Completed NCT NCT03011775

    Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease

    Not yet reported Ukrainian Medical Stomatological Academy 43 participants Est. completion 2015-09 1 site
    Other conditions: Adverse Effect, Atherosclerosis, Coronary, Insulin Resistance Syndrome
    View official trial listing →
  • Status unknown NCT NCT03015974

    Registry of IgA Nephropathy in Chinese Children

    Peking University First Hospital 1200 participants Est. completion 2024-12 1 site
    Other conditions: IgA Nephropathy, Proteinuria in Nephrotic Range, Immunosuppressive Treatment
    View official trial listing →
  • Completed NCT NCT03034265

    New Biomarkers and Difficult-to-treat Hypertension

    Insel Gruppe AG, University Hospital Bern 24 participants Est. completion 2017-05 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03066804

    A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients

    Not yet reported Novartis Pharmaceuticals 2572 participants Est. completion 2019-10-28 380 sites
    Heart failure
    View official trial listing →
  • Suspended NCT NCT03071653

    Left Cardiac Sympathetic Denervation for Cardiomyopathy Feasibility Pilot Study

    Not yet reported University of Cape Town 30 participants Est. completion 2022-02 1 site
    Other conditions: Dilated Cardiomyopathy, Ischemic Cardiomyopathy, Non-ischemic Cardiomyopathy
    View official trial listing →
  • Terminated NCT NCT03082014

    Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function

    Not yet reported Ludwig-Maximilians - University of Munich 101 participants Est. completion 2022-07-28 5 sites
    Other conditions: Cerebral Small Vessel Diseases
    View official trial listing →
  • Terminated NCT NCT03094195

    Dose Response Study of EMA401 in Patients With Post-herpetic Neuralgia (PHN)

    Not yet reported Novartis Pharmaceuticals 130 participants Est. completion 2019-03-07 58 sites
    Other conditions: Post-herpetic Neuralgia
    View official trial listing →
  • Terminated NCT NCT03121092

    ACEI/ARB Study in Ambulatory and Day of Surgery Admission Patients

    Not yet reported State University of New York - Downstate Medical Center 188 participants Est. completion 2017-03-07 1 site
    Other conditions: Hypertension, Hypotension
    View official trial listing →
  • Completed NCT NCT03122834

    Effect of Genetic Polymorphism on the Clinical Outcome of Patients With Heart Failure

    Ain Shams University 246 participants Est. completion 2024-06-14 1 site
    Heart failure
    View official trial listing →
  • Active, not recruiting NCT NCT03127631

    A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

    Not yet reported McMaster University 5000 participants Est. completion 2026-12-31 61 sites
    Cardiovascular disease Other conditions: Prostate Cancer
    View official trial listing →
  • Suspended NCT NCT03159988

    Angiotensin (1-7) Treatment to Improve Cognitive Functioning in Heart Failure Patients

    Not yet reported University of Arizona 6 participants Est. completion 2026-06-01 1 site Stand-alone
    Heart failure Other conditions: Cognitive Impairment
    View official trial listing →
  • Suspended NCT NCT03180450

    The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF)

    Not yet reported, Not yet reported Sclnow Biotechnology Co., Ltd. 60 participants Est. completion 2026-12-31 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT03190304

    The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure

    Not yet reported University of Sao Paulo General Hospital 52 participants Est. completion 2020-09-23 1 site
    Heart failure Other conditions: Exercise Tolerance, Vasodilation, Body Composition, Muscle Strength
    View official trial listing →
  • Terminated NCT NCT03212690

    Study of Renin-angiotensin System in Mechanically Ventilated Subjects

    Not yet reported GlaxoSmithKline 57 participants Est. completion 2019-07-08 2 sites
    Other conditions: Acute Lung Injury
    View official trial listing →
  • Completed NCT NCT03217591

    A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria

    Not yet reported Akebia Therapeutics 156 participants Est. completion 2019-08-20 54 sites
    Type 2 diabetesChronic kidney disease
    View official trial listing →
  • Completed NCT NCT03217825

    Antihypertensive Effect of Different Doses of Rostafuroxin in Comparison With Losartan

    Not yet reported Windtree Therapeutics 240 participants Est. completion 2018-02-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03244514

    Biomarker-guided Implementation of the AKI Bundle

    Not yet reported University Hospital Muenster 280 participants Est. completion 2020-01-26 12 sites Stand-alone
    Other conditions: Acute Kidney Injury (Nontraumatic)
    View official trial listing →
  • Completed NCT NCT03255551

    Blood Pressure Lowering Effects of Amosartan Regarding Proviso iN Patients With High Blood Pressure

    Seoul National University Bundang Hospital 50 participants Est. completion 2015-12-31
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03265574

    PROACT: Can we Prevent Chemotherapy-related Heart Damage in Patients With Breast Cancer and Lymphoma?

    Not yet reported South Tees Hospitals NHS Foundation Trust 111 participants Est. completion 2023-08-04 1 site Stand-alone
    Other conditions: Breast Cancer, Non Hodgkin Lymphoma
    View official trial listing →
  • Terminated NCT NCT03284099

    Bedtime ACEIs/ARBs Versus Morning ACEIs/ARBs for Reverting Non-dipping Hypertension

    Not yet reported Chinese University of Hong Kong 4 participants Est. completion 2019-12-31 1 site
    Other conditions: Hypertension, Non-Dipping
    View official trial listing →
  • Terminated NCT NCT03297294

    Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN)

    Not yet reported Novartis Pharmaceuticals 142 participants Est. completion 2019-03-25 64 sites
    Other conditions: Painful Diabetic Neuropathy
    View official trial listing →
  • Completed NCT NCT03310684

    Pediatric Primary Hypertension and the Renin-Angiotensin System (PHRAS)

    Wake Forest University Health Sciences 35 participants Est. completion 2023-04-26 1 site
    Other conditions: Pediatric Disorder, Pediatric Obesity, Primary Hypertension
    View official trial listing →
  • Withdrawn NCT NCT03315832

    Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study

    Not yet reported, Not yet reported University Hospital, Limoges Est. completion 2025-07-02 1 site Stand-alone
    Other conditions: Aortic Valve Stenosis, Valsartan, Angiotensin Receptor Antagonists, Transcatheter Aortic Valve Replacement, Heart Valve Prosthesis Implantation, Hypertrophy, Left Ventricular
    View official trial listing →
  • Completed NCT NCT03354143

    Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)

    Not yet reported University of Texas Southwestern Medical Center 85 participants Est. completion 2024-03-30 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03374449

    Impact of Renin-Angiotensin System Inhibitors Continuation on Outcome After Major Surgery

    Not yet reported Assistance Publique - Hôpitaux de Paris 2222 participants Est. completion 2023-12-24 1 site
    Other conditions: Renin Angiotensin System, Surgery
    View official trial listing →
  • Completed NCT NCT03381716

    Correlation Between Sex and Prognosis of Acute Aortic Dissection in the Chinese Population

    Shenyang Northern Hospital 884 participants Est. completion 2016-05-29
    Other conditions: Acute Aortic Dissection, Sex Role
    View official trial listing →
  • Active, not recruiting NCT NCT03418779

    Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD

    Not yet reported, Not yet reported Guang'anmen Hospital of China Academy of Chinese Medical Sciences 60 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: IgA Nephropathy at High Risk of Developing ESRD
    View official trial listing →
  • Completed NCT NCT03431077

    A Study of LJPC-501 in Pediatric Patients With Hypotension

    Not yet reported La Jolla Pharmaceutical Company 2 participants Est. completion 2018-04-14 3 sites Stand-alone
    Other conditions: Catecholamine-resistant Hypotension (CRH), Distributive Shock, High Output Shock, Sepsis
    View official trial listing →
  • Completed NCT NCT03466775

    Anti-Angiotensin II Type 1 Receptor Antibodies and Kidney Transplant Outcomes

    Paris Translational Research Center for Organ Transplantation 1845 participants Est. completion 2017-12-31 2 sites
    Other conditions: Kidney Transplant Failure and Rejection
    View official trial listing →
  • Completed NCT NCT03482440

    Angiotensin II and Chronic Inflammation in Persistent Microvascular Dysfunction Following Preeclampsia

    Not yet reported University of Iowa 24 participants Est. completion 2022-12-31 2 sites
    Other conditions: Preeclampsia
    View official trial listing →
  • Completed NCT NCT03489993

    FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)

    Wake Forest University Health Sciences 8 participants Est. completion 2020-12-23 1 site
    Other conditions: Hypophosphatemia, X-linked Hypophosphatemia, Renin-angiotensin System, Left Ventricular Hypertrophy
    View official trial listing →
  • Status unknown NCT NCT03526042

    Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus Nephritis

    Not yet reported Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 40 participants Est. completion 2019-10-31 1 site Stand-alone
    Other conditions: Atherosclerosis, Lupus Nephritis
    View official trial listing →
  • Status unknown NCT NCT03533153

    Intravenous MSC Therapy on Ischemia-Reperfusion Injury in Patients With Myocardial Infarction

    Not yet reported, Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 90 participants Est. completion 2025-12-30 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT03535935

    Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease

    Not yet reported, Not yet reported The University of Hong Kong 118 participants Est. completion 2022-12-31 2 sites Stand-alone
    Chronic kidney disease Other conditions: Diabetic Nephropathies
    View official trial listing →
  • Status unknown NCT NCT03573102

    Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients

    Not yet reported Nahla H Tohami 60 participants Est. completion 2020-07 1 site
    Other conditions: Diabetic Nephropathies
    View official trial listing →
  • Terminated NCT NCT03686696

    Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT

    Not yet reported Uppsala University 198 participants Est. completion 2023-08-22 32 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03695120

    RAAS Optimization for Acute CHF Patients

    Not yet reported University of Florida 1 participants Est. completion 2021-04-12 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT03722524

    The Use of TrIple Fixed-dose Combination in the Treatment of Arterial Hypertension

    Servier Russia 1247 participants Est. completion 2019-07-17 51 sites
    Other conditions: Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT03777215

    Angiotensin-(1-7) and Energy Expenditure in Human Obesity

    Not yet reported Amy Arnold 27 participants Est. completion 2026-04-15 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03785405

    Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF

    Not yet reported Novartis Pharmaceuticals 216 participants Est. completion 2023-12-29 79 sites
    Heart failure
    View official trial listing →
  • Active, not recruiting NCT NCT03856632

    Liraglutide Effect in Atrial Fibrillation

    Not yet reported University of Miami 60 participants Est. completion 2026-12-31 1 site Added to GLP-1
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT03887013

    Cardiac Metabolic Modulator Treatment for Improvement of Diastolic Function in Patients With Coronary Heart Disease

    Not yet reported China National Center for Cardiovascular Diseases 226 participants Est. completion 2020-12 1 site
    Other conditions: Coronary Heart Disease, Diastolic Dysfunction
    View official trial listing →
  • Completed NCT NCT03888066

    Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)

    Not yet reported Vifor Pharma, Inc. 1195 participants Est. completion 2021-09-02 415 sites
    Other conditions: Hyperkalemia
    View official trial listing →
  • Completed NCT NCT03921736

    Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.

    Not yet reported Anna Posadzy-Małaczyńska 180 participants Est. completion 2005-11-17
    Other conditions: Hypertension, Hyperuricemia, Menopause
    View official trial listing →
  • Active, not recruiting NCT NCT03938389

    The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans

    Not yet reported Ohio State University 90 participants Est. completion 2026-06 1 site
    Prediabetes Other conditions: Obesity, Blood Pressure
    View official trial listing →
  • Completed NCT NCT03949075

    Impact of Angiotensin Converting Enzyme Activity on Exercise Training Sensitivity

    Not yet reported University of Copenhagen 52 participants Est. completion 2019-12-30 1 site
    Other conditions: Exercise, Angiotensin-Converting Enzyme Inhibitors
    View official trial listing →
  • Completed NCT NCT03952390

    Effect of Renin-Angiotensin System on Platelet in Patient With Sepsis

    Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 53 participants Est. completion 2019-12-15 1 site
    Other conditions: Sepsis
    View official trial listing →
  • Completed NCT NCT03953872

    Antihypertensives in Non-cardiac Surgical Population

    RenJi Hospital 351 participants Est. completion 2019-04-01 1 site
    Other conditions: Perioperative Antihypertensive
    View official trial listing →
  • Status unknown NCT NCT03953950

    Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients

    Not yet reported Chiang Mai University 84 participants Est. completion 2020-12 1 site
    Other conditions: End Stage Renal Disease, Peritoneal Dialysis
    View official trial listing →
  • Completed NCT NCT03979976

    Ramipril, Endothelial Function and Endothelial Progenitor Cells in Patients With Systemic Lupus Erythematosus

    Not yet reported, Not yet reported Federal University of São Paulo 37 participants Est. completion 2013-09 1 site
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT04023227

    Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC

    Not yet reported Novartis Pharmaceuticals 922 participants Est. completion 2025-03-31 79 sites Stand-alone
    Heart failure Other conditions: Chagas Disease
    View official trial listing →
  • Completed NCT NCT04129840

    Identifying Most Effective Treatment Strategies to Control Arterial Hypertension in Sub-Saharan Africa

    Not yet reported University Hospital, Basel, Switzerland 1268 participants Est. completion 2022-09-22 3 sites
    Other conditions: Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT04141800

    Spanish Study of Hyperkalaemia Incidence and Prognosis in Patients With Heart Failure and Reduced Ejection Fraction

    Spanish Society of Cardiology 565 participants Est. completion 2021-03-31 1 site
    Heart failure Other conditions: Hyperkalemia
    View official trial listing →
  • Terminated NCT NCT04149990

    Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI

    Not yet reported Jacob Moller 51 participants Est. completion 2023-06-06 2 sites
    Cardiovascular disease Other conditions: Diastolic Dysfunction
    View official trial listing →
  • Status unknown NCT NCT04217135

    The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation

    Not yet reported Kaohsiung Veterans General Hospital. 400 participants Est. completion 2022-07-31 1 site
    Heart failure Other conditions: Mitral Regurgitation
    View official trial listing →
  • Completed NCT NCT04218435

    Impact of Sacubitril/Valsartan on Quality of Life and Mortality of CKD vs Non-CKD in Heart Failure Patients

    Clinision 200 participants Est. completion 2020-12-30 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT04254042

    Comparative Effects of Perindopril and Zofenopril on Blood Pressure Control and Oxidative Status Blacks Hypertensive Patients.

    Not yet reported Yaounde Central Hospital 24 participants Est. completion 2019-05-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT04270071

    Efficacy and Safety of Yangxin Shengmai Granules for the Treatment of Stable Angina Pectoris

    Not yet reported Guang'anmen Hospital of China Academy of Chinese Medical Sciences 80 participants Est. completion 2021-12 Stand-alone
    Other conditions: Coronary Heart Disease, Stable Angina
    View official trial listing →
  • Status unknown NCT NCT04270279

    Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris

    Not yet reported Guang'anmen Hospital of China Academy of Chinese Medical Sciences 120 participants Est. completion 2021-10 Stand-alone
    Other conditions: Coronary Heart Disease, Stable Angina
    View official trial listing →
  • Withdrawn NCT NCT04287686

    Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19

    Not yet reported The First Affiliated Hospital of Guangzhou Medical University Est. completion 2020-04 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04318418

    ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19

    Neuromed IRCCS 3400 participants Est. completion 2020-06-30 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Suspended NCT NCT04330300

    Coronavirus (COVID-19) ACEi/ARB Investigation

    Not yet reported National University of Ireland, Galway, Ireland 2414 participants Est. completion 2021-12-01 1 site
    Other conditions: Hypertension, COVID-19
    View official trial listing →
  • Status unknown NCT NCT04331574

    Renin-Angiotensin System Inhibitors and COVID-19

    Societa Italiana dell'Ipertensione Arteriosa 2000 participants Est. completion 2020-04-30 1 site
    Cardiovascular disease Other conditions: COVID-19, Hypertension
    View official trial listing →
  • Status unknown NCT NCT04337190

    Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2)

    University Hospital, Angers 100 participants Est. completion 2020-12-06 1 site
    Other conditions: COVID, Acute Respiratory Distress Syndrome
    View official trial listing →
  • Completed NCT NCT04338009

    Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019

    Not yet reported University of Pennsylvania 152 participants Est. completion 2020-08-20 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Not yet recruiting NCT NCT04345406

    Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19

    Not yet reported Tanta University 60 participants Est. completion 2029-12-01 1 site
    Other conditions: COVID
    View official trial listing →
  • Completed NCT NCT04351581

    Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With and Without COVID-19

    Not yet reported University Hospital, Gentofte, Copenhagen 78 participants Est. completion 2022-12-22 2 sites
    Other conditions: Covid-19
    View official trial listing →
  • Status unknown NCT NCT04356417

    Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse

    Assistance Publique - Hôpitaux de Paris 6000000 participants Est. completion 2020-06 1 site
    Other conditions: AMD, ACEi's/ARB Prevent/Worsen Risk of COVID-19 Infection
    View official trial listing →
  • Terminated NCT NCT04360551

    Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients

    Not yet reported University of Hawaii 24 participants Est. completion 2022-04-26 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04364113

    The Modification of Diet in Renal Disease Study

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 840 participants Est. completion 2000-12-31 Stand-alone
    Other conditions: Chronic Renal Disease
    View official trial listing →
  • Completed NCT NCT04364139

    African American Study of Kidney Disease and Hypertension

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1094 participants Est. completion 2007-06-30 Stand-alone
    Other conditions: Hypertensive Nephrosclerosis, Chronic Renal Insufficiency
    View official trial listing →
  • Completed NCT NCT04367051

    Pilot Study on Withdrawal of Spironolactone Among Heart Failure With Improved Ejection Fraction

    Not yet reported Asan Medical Center 62 participants Est. completion 2022-06-30 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT04371289

    Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up

    Istituto Auxologico Italiano 4356 participants Est. completion 2021-09-10 1 site
    Other conditions: COVID-19, Cardiovascular Risk Factor
    View official trial listing →
  • Status unknown NCT NCT04374110

    Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19

    National Institute of Cardiology, Warsaw, Poland 1000 participants Est. completion 2021-08-24 1 site
    Cardiovascular disease Other conditions: COVID, Hypertension, Cardiovascular Risk Factor
    View official trial listing →
  • Completed NCT NCT04378387

    Ipsilateral and Contralateral Index for the Interpretation of Adrenal Vein Sampling (AVS) in Primary Aldosteronism

    University of Turin, Italy 60 participants Est. completion 2020-04-30 1 site
    Other conditions: Primary Aldosteronism, Primary Aldosteronism Due to Aldosterone Producing Adenoma, Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
    View official trial listing →
  • Completed NCT NCT04397302

    Role of Sacubitril/Valsartan in the Improvement of Heart Failure With Reduced Ejection Fraction

    Italian Society of Cardiology 652 participants Est. completion 2020-03-16 1 site
    Heart failure Other conditions: Left Ventricular Dysfunction, Ventricular Remodeling
    View official trial listing →
  • Status unknown NCT NCT04401228

    Predictive Models for Intensive Care Admission and Death of COVID-19

    Clinique Saint Pierre Ottignies 60 participants Est. completion 2021-01-01 1 site
    Other conditions: COVID19, Pneumonia, Viral, Inflammatory Response
    View official trial listing →
  • Completed NCT NCT04401423

    TXA127 for the Treatment of Severe COVID-19

    Not yet reported Columbia University 22 participants Est. completion 2021-06-10 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT04434365

    Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease

    Not yet reported, Not yet reported Peking Union Medical College Hospital 24 participants Est. completion 2020-12-30 1 site Stand-alone
    Cardiovascular disease Other conditions: Percutaneous Coronary Intervention
    View official trial listing →
  • Status unknown NCT NCT04458285

    Efficacy and Safety of Sacubitril/Valsartan in Maintenance Hemodialysis Patients With Heart Failure

    Not yet reported Guangdong Provincial People's Hospital 118 participants Est. completion 2020-12-31 1 site Stand-alone
    Heart failure Other conditions: Hemodialysis Complication
    View official trial listing →
  • Completed NCT NCT04467931

    ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

    University of Utah 22213 participants Est. completion 2020-12-31 1 site
    Other conditions: Hypertension, COVID
    View official trial listing →
  • Status unknown NCT NCT04473703

    Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor in NSCLC Patients

    Shanghai Chest Hospital 300 participants Est. completion 2023-08-01
    Other conditions: Adverse Reactions, Immune Checkpoint Inhibitor, Non-Small Cell Lung Cancer Patients, Cardiac Event
    View official trial listing →
  • Completed NCT NCT04498780

    Hemodynamic Effects of ARNI on Noninvasive Pressure-volume Analysis in Patients With Chronic Heart Failure

    University of Leipzig 117 participants Est. completion 2026-04-08 2 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT04508985

    The McGill RAAS-COVID-19 Trial

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 46 participants Est. completion 2021-04-17 1 site
    Cardiovascular disease Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT04524156

    COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2

    Not yet reported Erasme University Hospital 100 participants Est. completion 2023-05-04 1 site
    Other conditions: COVID, Acute Respiratory Distress Syndrome, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT04524494

    Human Intestinal Amino Acid Absorption and the Role of a Local RAS

    University Children's Hospital Basel 50 participants Est. completion 2011-05-31 2 sites
    Other conditions: Renin-Angiotensin Aldosterone System (RAS)
    View official trial listing →
  • Completed NCT NCT04529005

    Angiotensin II in the Perioperative Management of Hypotension in Kidney Transplant Recipients

    Not yet reported University of Illinois at Chicago 20 participants Est. completion 2021-08-01 1 site Stand-alone
    Other conditions: Shock, Surgical, Shock, Hypotension and Shock, Kidney Transplant; Complications, Intraoperative Hypotension, Postoperative Hypotension
    View official trial listing →
  • Withdrawn NCT NCT04531397

    Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease

    Not yet reported Children's Hospital of Fudan University Est. completion 2022-12-31 1 site
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Status unknown NCT NCT04537585

    COVID-19: Collecting Measurements of Renin-angiotensin-system Markers, Such as Angiotensin-2 and Angiotensin 1-7

    Not yet reported Guyguy K Tshima, MD 2000 participants Est. completion 2022-12 1 site
    Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT04538924

    Etiologic Mechanisms, Myocardial Changes and Prognosis of Patients With MINOCA

    Not yet reported Vilnius University Hospital Santaros Klinikos 150 participants Est. completion 2023-01-01 1 site
    Cardiovascular disease
    View official trial listing →
  • Active, not recruiting NCT NCT04592744

    Angiotensin 2 for AKI After OLT

    Not yet reported University of California, Los Angeles 30 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Cirrhosis, Liver, End Stage Liver DIsease, Acute Kidney Injury, Liver Transplant; Complications
    View official trial listing →
  • Status unknown NCT NCT04604938

    The Effects of Losartan on Reward Reinforcement Learning

    Not yet reported University of Electronic Science and Technology of China 60 participants Est. completion 2022-03-31 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04633772

    Use of Angiotensin-(1-7) in COVID-19

    Not yet reported, Not yet reported Erasme University Hospital 112 participants Est. completion 2021-11-01 2 sites Stand-alone
    Other conditions: Infection, Coronavirus, Respiratory Failure
    View official trial listing →
  • Completed NCT NCT04647552

    Effects of Hydrocortison Treatment on Angiotensin II and Angiotensin II Receptors in Patients With Septic Shock

    Inonu University 40 participants Est. completion 2021-02-06 2 sites
    Other conditions: Shock, Septic
    View official trial listing →
  • Status unknown NCT NCT04687111

    Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation

    Not yet reported Mark Ledwidge 250 participants Est. completion 2021-06-11 2 sites Stand-alone
    Other conditions: Atrial Remodeling, Myocardial Dysfunction, Left Ventricular Remodeling, Left Ventricular Diastolic Dysfunction, Hypertension, Cardiovascular Morbidity, Fibrosis Myocardial, Inflammatory Myopathy, Atrial Arrhythmia
    View official trial listing →
  • Status unknown NCT NCT04716842

    Evaluation of Plasma Angiotensin II and Angiotensin II Receptor Levels in Patients With Sepsis and Septic Shock: a Prospective Observational Study.

    Inonu University 75 participants Est. completion 2021-04 1 site
    Other conditions: Sepsis, Septic Shock
    View official trial listing →
  • Status unknown NCT NCT04743063

    Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty

    Brigham and Women's Hospital 40000 participants Est. completion 2022-12-31 1 site
    Heart failure Other conditions: Frailty
    View official trial listing →
  • Completed NCT NCT04753112

    Treatment of PH With Angiotensin II Receptor Blocker and Neprilysin Inhibitor in HFpEF Patients With CardioMEMS Device

    Not yet reported Germans Trias i Pujol Hospital 14 participants Est. completion 2021-09-20 1 site Stand-alone
    Other conditions: Pulmonary Hypertension
    View official trial listing →
  • Completed NCT NCT04766645

    ACE2 Gender Differences in Stroke With COVID-19

    Fondazione Don Carlo Gnocchi ETS 77 participants Est. completion 2023-01-31 1 site
    Other conditions: Neurologic Manifestations
    View official trial listing →
  • Status unknown NCT NCT04769778

    Renin Angiotensin System Blockade in Renal Transplant Patients With Presence of PECs in Urine

    Not yet reported Josep M Cruzado 180 participants Est. completion 2023-06 1 site
    Other conditions: Chronic Kidney Allograft Nephropathy
    View official trial listing →
  • Terminated NCT NCT04778059

    Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19

    Not yet reported US Biotest, Inc. 21 participants Est. completion 2022-05-10 1 site Stand-alone
    Other conditions: 2019 Novel Coronavirus Infection, COVID-19 Virus Infection, SARS Coronavirus 2 Infection, SARS-CoV-2 Infection, Respiratory Distress Syndrome, Adult, Adult Respiratory Distress Syndrome
    View official trial listing →
  • Completed NCT NCT04818801

    Safety, Reactogenicity and Immunogenicity Study of ReCOV

    Not yet reported Jiangsu Rec-Biotechnology Co., Ltd. 100 participants Est. completion 2022-05-05 2 sites Stand-alone
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04836182

    A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Participants With Chronic Heart Failure With Reduced Ejection Fraction

    Not yet reported Ionis Pharmaceuticals, Inc. 72 participants Est. completion 2023-01-11 19 sites
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT04842058

    Pathophysiologic Hemodynamics After Primary Unilateral Total Hip Arthroplasty in Patients Receiving ACEIs and ARBs

    Hvidovre University Hospital 24 participants Est. completion 2023-12-01 1 site
    Other conditions: Orthostatic Intolerance, Orthostatic Hypotension
    View official trial listing →
  • Status unknown NCT NCT04853758

    Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF.

    Not yet reported University of Sao Paulo General Hospital 200 participants Est. completion 2024-12-01 1 site
    Other conditions: Chagas Cardiomyopathy
    View official trial listing →
  • Withdrawn NCT NCT04899206

    ANGIOTENSIN AGENTS AND REDUCTION OF THE PRESCRIPTION OF ANTIDEPRESSANT DRUGS: A RETROSPECTIVE COHORT STUDY USING REAL-WORLD DATA

    Sebastian Videla Est. completion 2025-12-20 1 site
    Other conditions: ACE Inhibitors, ARB, Hypertension, Depression
    View official trial listing →
  • Active, not recruiting NCT NCT04901169

    Angiotensin II in Liver Transplantation

    Not yet reported, Not yet reported University of California, San Francisco 50 participants Est. completion 2027-03-18 1 site Stand-alone
    Other conditions: Liver Transplant; Complications, Vasoplegia
    View official trial listing →
  • Terminated NCT NCT04904562

    Angiotensin II for Distributive Shock

    Not yet reported Northwestern University 2 participants Est. completion 2024-07-01 1 site
    Other conditions: Distributive Shock
    View official trial listing →
  • Status unknown NCT NCT04912167

    The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial Infarction

    Not yet reported West China Hospital 376 participants Est. completion 2026-06 1 site Stand-alone
    Other conditions: STEMI
    View official trial listing →
  • Completed NCT NCT04924660

    Novel Experimental COVID-19 Therapies Affecting Host Response

    Not yet reported, Not yet reported Sean Collins 1060 participants Est. completion 2023-12-31 51 sites
    Other conditions: COVID-19, SARS-CoV-2 Infection, Coronavirus Infection
    View official trial listing →
  • Status unknown NCT NCT04929600

    Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.

    Not yet reported Shanghai Jiao Tong University School of Medicine 120 participants Est. completion 2023-12 1 site
    Other conditions: Hypertension, Left Ventricular Hypertrophy
    View official trial listing →
  • Completed NCT NCT04936035

    A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension

    Not yet reported Alnylam Pharmaceuticals 394 participants Est. completion 2024-12-05 75 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT05007054

    Long-Term Outcomes in Patients With Three-Vessel Disease

    The First Affiliated Hospital of Dalian Medical University 4300 participants Est. completion 2021-08-06 1 site
    Other conditions: Three Vessel Coronary Disease
    View official trial listing →
  • Status unknown NCT NCT05007262

    Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy

    Not yet reported Guizhou Bailing Group Pharmaceutical Co Ltd 240 participants Est. completion 2023-12-31 13 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetic Retinopathy
    View official trial listing →
  • Status unknown NCT NCT05045274

    The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction

    Not yet reported Assiut University 300 participants Est. completion 2022-09
    Cardiovascular disease Other conditions: Left Ventricular Systolic Dysfunction
    View official trial listing →
  • Completed NCT NCT05049616

    Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension

    Not yet reported The University of Texas Health Science Center, Houston 70 participants Est. completion 2023-09-01 1 site
    Other conditions: Hypertension in Pregnancy, Postpartum Preeclampsia
    View official trial listing →
  • Status unknown NCT NCT05053893

    Roxadustat Combined With Sacubitril Valsartan Sodium Tablets in the Treatment of Cardiorenal Anemia Syndrome

    Not yet reported The Affiliated Hospital of Qingdao University 40 participants Est. completion 2022-09-01 1 site
    Other conditions: Cardio-Renal Syndrome
    View official trial listing →
  • Completed NCT NCT05055570

    Angiotensin II Pathway and Postoperative Hypoxemia

    Beijing Anzhen Hospital 88 participants Est. completion 2022-06-01 1 site
    Other conditions: Aortic Dissection
    View official trial listing →
  • Completed NCT NCT05065645

    Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled APN01 Developed as Treatment for COVID-19

    Not yet reported Apeiron Biologics 40 participants Est. completion 2022-05-27 1 site
    Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT05089539

    The Effect of Angiotensin Receptor-Neprilysin Inhibition on Cardiac Fibrosis in Patients With HFpEF

    Not yet reported Chongqing Medical University 60 participants Est. completion 2022-04-01 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT05096143

    A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data

    Novartis Pharmaceuticals 42269 participants Est. completion 2020-10-19 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT05103332

    Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)

    Not yet reported Alnylam Pharmaceuticals 663 participants Est. completion 2024-09-13 110 sites
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT05122182

    Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19

    Not yet reported University of Sydney 49 participants Est. completion 2023-01-28 10 sites Stand-alone
    Other conditions: COVID-19, SARS-CoV2 Infection
    View official trial listing →
  • Withdrawn NCT NCT05157464

    Losartan Use to Mitigate Arthrofibrosis Following Total Join Arthroplasty

    Not yet reported NYU Langone Health Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Arthrofibrosis
    View official trial listing →
  • Completed NCT NCT05168787

    Efficacy and Safety of Sacubitril/Valsartan in African American Patients With Heart Failure With Reduced Ejection Fraction

    Methodist Health System 6558 participants Est. completion 2025-07-08 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT05173025

    Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and Hypertension

    Not yet reported Seoul National University Bundang Hospital 42 participants Est. completion 2023-12-31 1 site
    Type 2 diabetes Other conditions: Hypertension, Atherosclerosis, Renin Hypertension
    View official trial listing →
  • Completed NCT NCT05189015

    Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and Hypertension

    Not yet reported Seoul National University Bundang Hospital 80 participants Est. completion 2023-06-30 1 site
    Type 2 diabetes Other conditions: Angiotensin/Renin/Aldosterone Hypertension, Hypertension
    View official trial listing →
  • Withdrawn NCT NCT05193370

    Angiotensin II vs. Vasopressin in Septic Shock

    Not yet reported University of New Mexico Est. completion 2022-11-30 1 site Stand-alone
    Other conditions: Septic Shock
    View official trial listing →
  • Active, not recruiting NCT NCT05196035

    A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria

    Not yet reported Bayer 219 participants Est. completion 2027-05-10 132 sites
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT05212649

    Optimized Peak VO2 in Predicting Advanced HF

    Chang Gung Memorial Hospital 377 participants Est. completion 2021-07-30 1 site
    Heart failure Other conditions: Morality, Transplant; Failure, Heart
    View official trial listing →
  • Status unknown NCT NCT05240443

    Bariatric Surgery and Chronic Renal Disease

    Not yet reported McMaster University 60 participants Est. completion 2023-06-01 1 site Stand-alone
    Chronic kidney disease Other conditions: Bariatric Surgery, Obesity
    View official trial listing →
  • Status unknown NCT NCT05243446

    Cardiorenal Effecs of Losartan in Kidney Transplant Recipients

    Medical University of Gdansk 740 participants Est. completion 2023-12-31 1 site
    Other conditions: Renal Transplant Failure, Cardiovascular Complication
    View official trial listing →
  • Withdrawn NCT NCT05259137

    Intra-lesional ACE Inhibitor for Treatment of Hypertrophic Scars

    Not yet reported, Not yet reported Nova Scotia Health Authority Est. completion 2026-10
    Other conditions: Hypertrophic Scar
    View official trial listing →
  • Status unknown NCT NCT05269615

    Exercise-induced Erythropoiesis: the Mechanistic of Angiotensin II

    Not yet reported The University of Hong Kong 80 participants Est. completion 2024-09-30 1 site
    Other conditions: Exercise Physiology
    View official trial listing →
  • Status unknown NCT NCT05271448

    Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography

    Not yet reported An-Najah National University 600 participants Est. completion 2024-08-01 1 site
    Chronic kidney disease Other conditions: Contrast-induced Nephropathy, Ischemic Heart Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05272878

    Impact of a Treatment With Angiotensin Receptor Blocker on Outcome After Acute Kidney Injury in Patients Discharged From the ICU.

    Not yet reported Assistance Publique - Hôpitaux de Paris 508 participants Est. completion 2026-06-27 1 site
    Other conditions: Acute Kidney Injury
    View official trial listing →
  • Terminated NCT NCT05301192

    Angiotensin-(1-7) Cardiovascular Effects in Aging

    Not yet reported Milton S. Hershey Medical Center 4 participants Est. completion 2024-06-10 1 site Stand-alone
    Other conditions: Aging
    View official trial listing →
  • Status unknown NCT NCT05322200

    The POST-ACS Study

    Not yet reported Swansea Bay University Health Board 140 participants Est. completion 2024-08-01 1 site
    Cardiovascular disease Other conditions: Diabetes Mellitus, Acute Coronary Syndrome
    View official trial listing →
  • Status unknown NCT NCT05329727

    The Comparative Effectiveness Between ARNI and ACE Inhibitor/ARB Medication in Patient With HFrEF

    Wonju Severance Christian Hospital 1000000 participants Est. completion 2025-12-31 1 site
    Heart failure Other conditions: Mortality
    View official trial listing →
  • Active, not recruiting NCT NCT05331144

    Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)

    Not yet reported Rong Zhang 180 participants Est. completion 2028-08-31 1 site Stand-alone
    Other conditions: Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline, Family History of Dementia
    View official trial listing →
  • Status unknown NCT NCT05336175

    Biomarker Study: Heart Failure Patients at Risk

    Not yet reported, Not yet reported University of Arizona 40 participants Est. completion 2023-12 2 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT05419583

    Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction

    Not yet reported University of Edinburgh 60 participants Est. completion 2024-06-30 2 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05464745

    Bioequivalence Study of 8 mg Perindopril Tert-butylamine / 2.5 mg Indapamide Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide Film-coated Tablets in Healthy Volunteers

    Not yet reported Darnitsa Pharmaceutical Company 42 participants Est. completion 2021-06-09 1 site Stand-alone
    Other conditions: Bioequivalence, Healthy Subjects
    View official trial listing →
  • Completed NCT NCT05470764

    Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide / 10 mg Amlodipine Film-Coated Tablets in Healthy Volunteers

    Not yet reported Darnitsa Pharmaceutical Company 52 participants Est. completion 2021-06-28 1 site Stand-alone
    Other conditions: Bioequivalence, Healthy Subjects
    View official trial listing →
  • Completed NCT NCT05498181

    Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation

    Not yet reported Brigham and Women's Hospital 45 participants Est. completion 2026-01-31 1 site
    Other conditions: Hemodialysis
    View official trial listing →
  • Terminated NCT NCT05593770

    International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response

    Not yet reported, Not yet reported NEAT ID Foundation 28 participants Est. completion 2023-12-14 21 sites
    Other conditions: COVID-19, SARS-CoV2 Infection, Coronavirus Infection
    View official trial listing →
  • Status unknown NCT NCT05623358

    PHARM Optimal-HF Pilot

    Not yet reported University of British Columbia 42 participants Est. completion 2025-09-01 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Withdrawn NCT NCT05633758

    Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure

    Not yet reported Scripps Health Est. completion 2016-03 1 site
    Heart failure
    View official trial listing →
  • Active, not recruiting NCT NCT05637853

    Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction

    Not yet reported Göteborg University 60 participants Est. completion 2026-08-26 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT05745571

    Molecular Pathways of Cardiac Remodellation in Patients With Acute and Chronic Left Ventricular Disfunction

    Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 90 participants Est. completion 2023-12-10 1 site
    Heart failure Other conditions: Ischemic Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT05759754

    Effects of Traditional Chinese Medicine (GSJYF) in Children With Inherited Proteinuric Kidney Disease

    Not yet reported Children's Hospital of Fudan University 72 participants Est. completion 2024-12-01 9 sites Stand-alone
    Other conditions: Proteinuria, Kidney Diseases, Hereditary Nephropathy
    View official trial listing →
  • Status unknown NCT NCT05782881

    High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 16000 participants Est. completion 2024-12-31 107 sites
    Cardiovascular diseaseType 2 diabetes Other conditions: Coronary Disease
    View official trial listing →
  • Status unknown NCT NCT05818995

    Therapeutic Drug Use for CKD Patients

    Qianfoshan Hospital 10000 participants Est. completion 2024-06-30 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT05824767

    Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock

    Not yet reported University of New Mexico 42 participants Est. completion 2025-03-12 1 site Stand-alone
    Other conditions: Septic Shock, Vasodilatory Shock
    View official trial listing →
  • Active, not recruiting NCT NCT05824923

    A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure

    Not yet reported Pulnovo Medical (Wuxi) Co., Ltd. 264 participants Est. completion 2027-02 1 site Stand-alone
    Heart failureCardiovascular disease Other conditions: Pulmonary Hypertension, Hypertension, Vascular Diseases
    View official trial listing →
  • Completed NCT NCT05831644

    A Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 Diabetes

    Not yet reported Vicore Pharma AB 11 participants Est. completion 2023-06-20 1 site Stand-alone
    Other conditions: Type2diabetes, Endothelial Dysfunction
    View official trial listing →
  • Status unknown NCT NCT05839236

    COVID-19 Vaccination Detoxification in LDL-C

    Not yet reported Yang I. Pachankis 1 participants Est. completion 2023-07-31 1 site Stand-alone
    Cardiovascular disease Other conditions: COVID-19 Stress Syndrome, COVID-19 Vaccine Adverse Reaction, COVID-19-Associated Thromboembolism, COVID-19 Post-Intensive Care Syndrome, COVID-19 Respiratory Infection
    View official trial listing →
  • Status unknown NCT NCT05873400

    Effect of Renin Angiotensin Aldosterone System Genetic Polymorphism on the Pharmacological Effect of Mineralocorticoid Receptor Antagonists in Patients With Myocardial Infarction

    Ain Shams University 102 participants Est. completion 2024-04-01 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT05893108

    Ethosomal Gel Bearing Losartan 5% for Keloid Treatment

    Not yet reported, Not yet reported Yuni Eka Anggraini 46 participants Est. completion 2024-10-30 1 site
    Other conditions: Keloid
    View official trial listing →
  • Terminated NCT NCT05897372

    Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study

    Not yet reported Iain Bressendorff 1 participants Est. completion 2024-09-23 1 site
    Chronic kidney disease
    View official trial listing →
  • Status unknown NCT NCT05922852

    Effect of Novel Antidiabetic Drug Combined With Angiotensin Receptor/Neprilysin Inhibitor on Urinary Protein

    Peking University Third Hospital 1000 participants Est. completion 2024-02-28 2 sites
    Type 2 diabetes Other conditions: Antidiabetic Drugs
    View official trial listing →
  • Status unknown NCT NCT05972785

    Long-term Use of CCB and Breast Cancer Risk

    Curtin University 68500 participants Est. completion 2025-12 1 site
    Other conditions: Hypertension,Essential, Breast Cancer
    View official trial listing →
  • Completed NCT NCT05990296

    Evaluating Strategies to Improve Guideline Directed Medical Therapy: The GDMT Research, Education & Assist Trial for Heart Failure Care

    Not yet reported Geisinger Clinic 4306 participants Est. completion 2025-05-17 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT06072508

    Prognostic Interest of Vasorin in Septic Shock

    Not yet reported Centre Hospitalier Universitaire, Amiens 50 participants Est. completion 2025-03-29 1 site
    Other conditions: Sepsis, Acute Kidney Injury
    View official trial listing →
  • Completed NCT NCT06088849

    Maternal Treatment With ACE-inhibitors and Breastfeeding: a Mono-centric Study on the Exposure Through Breast Milk

    Not yet reported Universitaire Ziekenhuizen KU Leuven 20 participants Est. completion 2023-12-31 1 site
    Heart failure Other conditions: Breast Feeding, Hypertension, Proteinuria
    View official trial listing →
  • Status unknown NCT NCT06090617

    Water and Electrolytes Content in HYpertension (WHYSKI) in the SKIn

    University Hospital Padova 35 participants Est. completion 2025-01-01 1 site
    Other conditions: Hyperaldosteronism, Hypertension, Aldosterone-producing Adenoma, Aldosteronism, Aldosterone Disorder, Essential Hypertension, Bilateral Adrenal Hyperplasia, Conn Adenoma
    View official trial listing →
  • Status unknown NCT NCT06122987

    Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock

    Not yet reported Kingman Regional Medical Center 50 participants Est. completion 2025-01 1 site Stand-alone
    Other conditions: Septic Shock, Shock, Sepsis, Systemic Inflammatory Response Syndrome
    View official trial listing →
  • Completed NCT NCT06155812

    Multimodal Vasopressor Strategy in Septic Shock

    Not yet reported, Not yet reported University Medical Centre Maribor 79 participants Est. completion 2026-02-01 2 sites Stand-alone
    Other conditions: Shock, Septic
    View official trial listing →
  • Completed NCT NCT06247371

    Impact of a Novel Heart Failure Medication Decision Aid

    Not yet reported National University of Singapore 150 participants Est. completion 2025-02-10 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT06253429

    Alpha-lipoic Acid in Diabetic Nephropathy

    Not yet reported Ain Shams University 30 participants Est. completion 2024-02-01 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT06382571

    Factors Associated With Sub - Targeted Therapeutic Dose Of Renin - Angiotensin Blockage Among Chronic Heart Failure With Reduced Ejection Fraction Patients

    Chulalongkorn University 396 participants Est. completion 2021-12-31
    Heart failure
    View official trial listing →
  • Completed NCT NCT06395194

    Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension

    Not yet reported Oslo University Hospital 15313 participants Est. completion 2003-12-05
    Other conditions: Essential Hypertension
    View official trial listing →
  • Status unknown NCT NCT06417320

    Effect of Sodium-glucose Cotransporter-2 Inhibitors (SGLT-2i) on Proteinuria in Nephrotic Children Older Than 10 Years

    Not yet reported Mansoura University 60 participants Est. completion 2025-08 1 site
    Other conditions: Nephrotic Syndrome in Children
    View official trial listing →
  • Completed NCT NCT06425705

    Impact of Silymarin Adjunct Therapy on Proteinuria in Type 2 Diabetic Patients on RAS Inhibitors

    Not yet reported Lahore General Hospital 70 participants Est. completion 2023-07-10 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT06499948

    Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients With Alport Syndrome (COMBINE-ALPORT)

    Not yet reported Stefan Lujinschi 12 participants Est. completion 2026-04-30 1 site Stand-alone
    Other conditions: Alport Syndrome, Thin Basement Membrane Disease, Alport Nephropathy
    View official trial listing →
  • Completed NCT NCT06500000

    The Plasma Metabolomics Profiling of Primary Aldosteronism

    Third Military Medical University 95 participants Est. completion 2023-05-19 1 site
    Other conditions: Primary Aldosteronism, Essential Hypertension, Idiopathic Aldosteronism, Aldosterone-producing Adenoma
    View official trial listing →
  • Status unknown NCT NCT06501651

    Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy

    Not yet reported Sichuan Academy of Medical Sciences 297 participants Est. completion 2025-04-10 1 site Stand-alone
    Type 2 diabetes Other conditions: Essential Hypertension, Nephropathy
    View official trial listing →
  • Status unknown NCT NCT06515678

    Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension

    Groupe Hospitalier Pitie-Salpetriere 9464 participants Est. completion 2024-08-31 2 sites
    Other conditions: Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab, Hypertension
    View official trial listing →
  • Active, not recruiting NCT NCT06532682

    Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 54 participants Est. completion 2026-10-01 1 site
    Chronic kidney disease Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT06555146

    Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and Nephropathy

    Not yet reported Bispebjerg Hospital 15 participants Est. completion 2025-03 1 site
    Type 2 diabetes Other conditions: Kidney Disease, Chronic
    View official trial listing →
  • Withdrawn NCT NCT06608472

    Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension

    Not yet reported Eurofarma Laboratorios S.A. Est. completion 2029-10-30
    Other conditions: Essential Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT06690723

    Vitamin D and SGLT-2 Inhibitor in CPAP-naive Obstructive Sleep Apnea

    Not yet reported University Malaysia Sarawak 160 participants Est. completion 2024-09-03 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT06697353

    An Observational Study to Learn More About the Real-world Outcomes in Patients With Heart Failure Who Initiate Treatment With Vericiguat in Japan

    Bayer 4936 participants Est. completion 2025-09-19 1 site
    Heart failure
    View official trial listing →
  • Not yet recruiting NCT NCT06746753

    Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock

    Not yet reported Wake Forest University Health Sciences 78 participants Est. completion 2028-10-07 2 sites Stand-alone
    Other conditions: Septic Shock
    View official trial listing →
  • Completed NCT NCT06764277

    Mechanisms and Phenotypes of Hypertension in Patients in Chronic Hemodialysis

    Bernardo Rodríguez Iturbe 32 participants Est. completion 2025-06-06 1 site
    Other conditions: Arterial Hypertension, Hemodialysis
    View official trial listing →
  • Completed NCT NCT06862115

    The Effect of Discontinuation of Renin Angiotensin System Inhibitors on the Perioperative Myocardial Injury in Adult Patients Undergoing Colorectal Cancer Surgery

    Not yet reported Kasr El Aini Hospital 182 participants Est. completion 2026-08-10 1 site
    Other conditions: Myocardium; Injury, Perioperative/Postoperative Complications, Angiotensin-Converting-Enzyme Inhibitor
    View official trial listing →
  • Active, not recruiting NCT NCT06895213

    Evaluation of Plasma Renin Concentrations in Cardiac Surgery

    Mayo Clinic 100 participants Est. completion 2026-12 1 site
    Other conditions: Cardiac Surgery With Cardiopulmonary Bypass
    View official trial listing →
  • Completed NCT NCT07023016

    Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure

    Not yet reported, Not yet reported National Heart Institute, Egypt 515 participants Est. completion 2025-02-28 2 sites
    Heart failureChronic kidney disease
    View official trial listing →
  • Not yet recruiting NCT NCT07032116

    YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1

    Liu Hongfang 4472 participants Est. completion 2028-07-31 5 sites
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT07088471

    Cardiac Left Atrial Evaluation and Response in HFrEF With Sacubitril/Valsartan

    Connolly Hospital Blanchardstown 334 participants Est. completion 2025-08-01 1 site
    Heart failure
    View official trial listing →
  • Enrolling by invitation NCT NCT07181135

    FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors

    Not yet reported University Medical Center Groningen 180 participants Est. completion 2027-12-31 8 sites Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Not yet recruiting NCT NCT07261098

    The Efficacy and Safety of ARNI on the Outcome of Advanced Lung Cancer With Concurrent Hypertension

    Not yet reported Shanghai Chest Hospital 200 participants Est. completion 2028-12-31
    Other conditions: Advanced Lung Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07262710

    Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 13656 participants Est. completion 2026-08-19
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT07315139

    Pentoxifylline on Inflammatory Markers in Non-Diabetic Chronic Kidney Disease Patients

    Not yet reported Ain Shams University 42 participants Est. completion 2023-08-31 1 site
    Chronic kidney disease Other conditions: Pentoxifylline, Inflammatory Markers, Non-Diabetic
    View official trial listing →
  • Not yet recruiting NCT NCT07583992

    Multicenter Phase II Trial of NRICM102 Combined With Standard Therapy in Pneumonia

    Not yet reported National Research Institute of Chinese Medicine, Ministry of Health and Welfare 150 participants Est. completion 2027-11 1 site Stand-alone
    Other conditions: Mild to Moderate, Community-Acquired Pneumonia (CAP), Antibiotic Therapy, Intravenous, Hospitalisation
    View official trial listing →
  • Not yet recruiting NCT NCT07602166

    Effect of an Isolevuglandin Scavenger on Salt Sensitivity of Blood Pressure and Immune Cell Activation in Humans

    Not yet reported Vanderbilt University Medical Center 20 participants Est. completion 2031-07 1 site
    Other conditions: Salt Sensitivity of Blood Pressure, High Blood Pressure, Inflammation, Renin-Angiotensin-Aldosterone System
    View official trial listing →
  • Completed NCT NCT07666607

    Pathological Mechanism Study of Aerobic Exercise Regulating Cold Stress-induced Hypertension Via the Thermosensitive Target-mediated Sympathetic Nerve Pathway

    Wang Jingfeng 200 participants Est. completion 2025-12-28 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Not yet recruiting NCT NCT07671365

    Angiotensin II for Post Cardiac Surgery Vasoplegia (ANGII_V)

    Not yet reported Methodist Healthcare System of San Antonio 329 participants Est. completion 2030-08 Stand-alone
    Other conditions: Vasoplegic Shock, Cardiopulmonary Bypass, Vasoplegia
    View official trial listing →
  • Not yet recruiting NCT NCT07681726

    Project HOPE (Hypertension Outreach Through Partnership and Engagement)

    Johns Hopkins University 150 participants Est. completion 2027-09-30 1 site
    Other conditions: Hypertension (HTN)
    View official trial listing →
  • Not yet recruiting NCT NCT07735130

    Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR)

    Not yet reported Seoul National University Hospital 632 participants Est. completion 2030-06-15 1 site Stand-alone
    Other conditions: Transcatheter Aortic Valve Replacement (TAVR), Left Ventricular Hypertrophy, Severe Aortic Stenosis
    View official trial listing →
  • Completed NCT NCT07746908

    Bioequivalence Study of Valsatril Tablet Versus Entresto® Sacubitril/Valsartan 24/26 mg Tablet.

    Not yet reported Center for Bioequivalence Studies and Clinical Research 60 participants Est. completion 2025-07-18 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT07757048

    A Study of Treatment Patterns and Real-World Outcomes in IgA Nephropathy Patients in the United States

    Novartis Pharmaceuticals 6286 participants Est. completion 2026-07-01 1 site
    Other conditions: IGA Nephropathy
    View official trial listing →
  • Not yet recruiting NCT NCT07832942

    Beta-2 Adrenergic Receptor Polymorphic Variants: An Endotype of Salt Sensitive Hypertension (Beta2AR).

    Not yet reported Brigham and Women's Hospital 110 participants Est. completion 2030-04 1 site Stand-alone
    Other conditions: Genetics in Hypertension
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Angiotensin Ii, Angiotensin, Angiotensin-(1-7), Angiotensin I/II (1-7) Acetate

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.